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ABSTRACT 
 
Intestinal health is essential for the health of the body since the gastro-intestinal mucosa 
is the main site of interaction with the external environment, as well as the major area 
colonized by the microbiota. Intestinal health relies on proper barrier function, 
epithelial integrity and related mechanisms of protection (mucous layer, tight junctions, 
immune and inflammatory system). In pigs, during the weaning transition, intestinal 
inflammation and barrier integrity play a crucial role in regulating intestinal health and, 
consequently, pig’s health, growth and productivity. The aim of the project was to 
assess the impact of different nutritional strategies on the intestinal health of weaning 
piglets with reference to the inflammatory status and epithelial integrity. Therefore, in 
vivo trials were conducted to test the in-feed supplementation with zinc, tributyrin, or 
organic acids and nature-identical compounds (NIC) to weaning piglets. All the dietary 
interventions positively impacted the intestinal inflammatory status and, as a 
consequence, improved epithelial integrity by modulating tight junctions proteins (zinc 
or tributyrin) or by enhancing barrier properties measured with Ussing chambers 
(organic acids and NIC). These findings highlight that intestinal inflammation and 
barrier function are strictly linked, and that the control of inflammation is essential for 
adequate barrier function. In addition, in zinc trial and organic acids and NIC trial, 
better intestinal health could successfully result in better growth performance, as aimed 
for pig production improvement. To conclude, this work shows that dietary 
supplementation with bio-active substances such as zinc, tributyrin or organic acids and 
NIC may improve intestinal health of weaning piglets modulating intestinal 
inflammatory stress and barrier integrity and allowing better piglet’s health, growth and 
productivity. 
 
Keywords: weaning piglet, intestinal health, inflammatory cytokines, barrier integrity, 
tight junctions. 
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INTESTINAL BARRIER 
Animals are inhabited by a vast number of microorganisms, such as bacteria, viruses, 
and unicellular eukaryotes, collectively known as “microbiota”. The microbiota 
colonizes virtually every surface of the body that is exposed to the external 
environment, including the skin, and the mucosae of the airways, oral cavity, digestive 
tract and genitourinary tract. Among these multiple sites, the most heavily colonized 
organ is the gastro-intestinal tract (GIT), because of the huge surface area and the 
richness in substrates that can be used as nutrients by microbes. For example, it has 
been estimated that the human gut has a surface area of a tennis court (200 m
2
) and that 
the colon alone hosts over 70% of all the microbes in the human body (Sekirov et al., 
2010). Human gut microbiota comprises trillions of bacteria, consisting of more than 
800 different bacterial species and 7000 strains, that make essential contributions to 
host metabolism while occupying a protected and nutrient rich environment (Hooper & 
Macpherson, 2010). Therefore, the gastro-intestinal tract represents the largest mucosal 
interface between the continuously changing external environment (dense microbial 
community, dietary antigens and food components) and the closely regulated internal 
milieu. Under normal conditions, the relationship between intestine and microbiota is 
defined “homeostatic”, so that adverse health effects caused by intestinal 
microorganisms should be minimized even during environmental perturbations, 
including shifts in microbiota composition, changes in host diet or pathogenic 
challenges. According to Hooper and Macpherson, homeostasis is maintained by a 
hierarchy of three immunological barriers, aiming to limit the direct contact between 
intestinal bacteria and epithelial cells, to rapidly detect and kill bacteria that manage to 
penetrate epithelial cells, and to minimize the exposure of resident bacteria to the 
systemic immune system (Hooper & Macpherson, 2010). For these purposes, a set of 
immune mechanisms and anatomical and functional structures have been established at 
the intestinal level to form a ‒ double tasks ‒ selective intestinal barrier, allowing both 
digestion and absorption of food and protection from microbial challenges and toxic 
compounds. In this regard, the intestinal barrier function can be defined as the ability to 
control uptake across the mucosa and to protect the internal milieu from harmful 
substances present in the lumen (Barreau & Hugot, 2014). A schematic picture of the 
intestinal barrier structure is presented in Fig. 1 (adapted from Hooper & Macpherson, 
2010). 
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Fig. 1. Intestinal barrier structure 
(adapted from Hooper & Macpherson, 2010) 
 
The first line of defense is localized within the lumen itself and is represented by the 
mucous layer, the viscous gel-like layer that covers the intestinal epithelial cell surface. 
The mucous layer is composed by mucin glycoproteins secreted by epithelial goblet 
cells, and forms two structurally distinct strata. The outer –loosely adherent‒ mucous 
layer contains a great number of commensal bacteria that contribute to the host defense 
by secreting anti-microbial compounds and by competing for nutrients. The inner –
firmly adherent– mucous layer is a protected zone at the apical epithelial surface, 
devoid of bacteria due to the abundance of anti-microbial proteins (defensins, 
cathelicidins, C-type lectins) produced by epithelial cells such as enterocytes, Paneth 
cells and goblet cells, and IgA secreted by plasma cells residing in the lamina propria 
and trancsytosed across the epithelium. In addition, epithelial cell surface is covered by 
membrane-bound mucins and other membrane glycoproteins that form the glycocalix. 
The actual physical barrier is represented by the single cohesive monolayer of polarized 
epithelial cells, with the apical surface facing the lumen and the baso-lateral side 
overlying the lamina propria and muscularis mucosa layer. Underneath the epithelium, 
there are several elements of the gut-associated lymphoid tissue (GALT) that is 
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regarded as the largest lymphoid organ in the body. GALT comprises both inductive 
sites (mesenteric lymph nodes, isolated lymphoid follicles (ILFs), and Peyer’s patches 
in the ileum,) and effector sites (the epithelium itself and the underlying lamina 
propria), along with immune cells including intra-epithelial lymphocytes (IELs), IgA-
secreting plasma cells, M cells, macrophages and dendritic cells (DCs), the latter 
populations being involved in antigen sampling and presentation, respectively (Kim & 
Ho, 2010; Garrett et al., 2010). 
One of the two tasks of the intestinal epithelium is absorption and secretion, therefore, 
the flux of compounds across the epithelium can occur through both trans-cellular and 
para-cellular pathways. The trans-cellular transport is directional, energy dependent, 
and highly regulated by the cell-specific profile of transporters and channels localized 
on the apical and basolateral cell membranes. On the contrary, the para-cellular 
transport is passive, and involves movement through the space between adjacent cells 
(Anderson, 2001). The latter route can be potentially harmful for the penetration by 
pathogens or toxic compounds. Therefore, in order to regulate traffic through the para-
cellular pathway, mammalian epithelial cells form a series of intercellular junctions 
along their lateral margins to seal the interspace: closest to the apical surface lies the 
apical junction complex, formed by three individual junctions, tight junctions (TJ), 
adherens junctions and desmosomes, while underneath are the gap junctions (Fig. 2). 
 
 
Fig. 2. Intercellular junctions linking epithelial cells 
(adapted from Matter & Balda, 2003) 
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Components of the apical junction complex interact with cytoskeletal elements to 
strengthen their interactions. The adherens junctions, along with desmosomes, provide 
the strong adhesive force that keeps cellular proximity, though inter-space is still 
evident between the two adjoining cells. The adherens junctions are composed of E-
cadherin, and catenins (α- and β-catenin), whereas desmosomes are formed by 
interactions between desmoglein, desmocollin, and desmoplakin. Both structures are 
linked to cytoskeleton filaments, of F-actin and keratin, respectively. The actual sealing 
point is represented by tight junctions, that are also considered “kiss-points” between 
two cells. Tight junctions are the most apically located intercellular junctions and are 
multi-protein complexes composed of three different elements: integral membrane 
proteins, junctional complex proteins and cell cytoskeleton structures (see Fig. 3). The 
integral membrane proteins organize into fibrils crossing the plasma membrane to 
interact with proteins from adjoining cell. These proteins are claudins, occludin, and 
JAMs (junctional adhesion molecules). Among them, the most important are members 
of the claudin family (from latin «claudere = to close»), a family of 20 proteins, that 
actually seal the intercellular space between adjacent cells. According to Van Itallie and 
Anderson, claudins are responsible for selective permeability of TJ to water, ions, and 
small molecules, since they form aqueous pores within the TJ, (Van Itallie & Anderson, 
2004). 
In addition, occludin is a tetra-spanning transmembrane protein that interacts with 
claudins and other cytoplasmic proteins, and JAMs (junctional adhesion molecules) are 
integral membrane proteins (single transmembrane domain) that belong to 
immunoglobulin superfamily. On the intracellular side of the membrane, the carboxy-
terminal end of these proteins interacts with cytoplasmic junctional complex proteins 
belonging to the zonula occludens family (ZO-1, ZO-2, and ZO-3). Among them, the 
most important is zonula occludens 1 (ZO-1), a cytoplasmic protein that contains 
multiple protein interaction domains, and forms a scaffold for the transmembrane 
proteins (claudins and occludin) connecting them to the ring of actin microfilaments of 
the cell cytoskeleton. In addition, ZO-1 belongs to the membrane associated guanylate 
kinase superfamily and possesses an enzymatically inactive guanylate kinase-like 
domain, whose phosphorylation regulates TJ structure. Underneath the junctional 
complex lies a ring of actin microfilaments, linking TJ to cytoskeleton, whose 
contraction can separate TJ elements and has been proposed to regulate para-cellular 
permeability (Arrieta et al., 2006). 
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Fig. 3. Structure of tight junctions 
(from Kotler et al., 2013) 
 
Once considered static structures, TJ are actually extremely dynamic and the functional 
state is permanently modulated by various extracellular physiological, pharmacological, 
dietary, bacterial and inflammatory stimuli acting to activate intra-cellular signaling 
pathways and thus to regulate permeability. TJ permeability may be regulated directly 
through changes in TJ proteins or indirectly via the cytoskeleton, and theoretically all 
the TJ components described above can be considered as potential targets of TJ 
modulators. Deli and colleagues reported a series of  regulatory mechanisms such as 
MLCK (myosin light chain kinase), Rho, PKC (protein kinase C), and MAPK 
(mitogen-activated protein kinase) pathways that modulate the cytoskeleton-TJ proteins 
interactions (mainly through phosphorylation / dephosphorylation reactions), resulting 
in altered epithelial permeability (Deli et al., 2009).  
Proper and stable assembly of TJ is required for effective intestinal barrier function, 
and consequently for prevention of intestinal diseases. However, TJ formation has to be 
dynamic to allow intestinal epithelial cell turnover that occurs every 4-5 days. For this 
reason, under physiological conditions, TJ proteins are continuously internalized and 
recycled back to the plasma membrane via endocytosis (Guzman et al., 2013). 
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Intestinal Barrier and Inflammation 
Among the mediators of the TJ status, inflammatory cytokines are major regulators of 
intestinal epithelial permeability (Lallès, 2010). At the intestinal level, cytokines can be 
produced by several types of mucosal cells, including macrophages, activated T cells, 
mast cell, and epithelial cells. Table 1 is taken from a review on gut barrier homeostasis 
by Lallès, and summarizes the effects of different cytokines on intestinal barrier 
function and TJ proteins. Barrier function is expressed in terms of trans-epithelial 
electrical resistance (TEER) and para-cellular permeability (PCP), both 
electrophysiological parameters obtained from ex vivo Ussing chambers analysis of the 
epithelium. Generally, a reduction in TEER and an increase in PCP are index of a 
reduced barrier function. The ability of cytokines, such as IFN-γ and TNF-α, to regulate 
the function of the TJ barrier was first described over 20 years ago (Madara & Stafford, 
1989). Since then, various experiments conducted on epithelial cells, including 
intestinal Caco-2 cells, showed that both IFN-γ and TNF-α exert a TJ barrier disrupting 
effect (reduced TEER, enhanced PCP). According to Bruewer and colleagues, the pro-
inflammatory‒”leaky” action of IFN-γ is through the internalization of TJ proteins 
(mainly occludin) via macro-pinocytosis (Bruewer et al., 2005). Synergistically, TNF-α 
can increase intestinal permeability probably through the reduction in TJ strands 
mediated by the activation of NF-kB and the MLCK pathway (Al-Sadi et al., 2009). In 
addition, TNF-α has a pro-apoptotic action on epithelial cells and dying cell can cause a 
gap in the cellular lining, thus challenging barrier function (Gitter et al., 2000). 
However, anti-inflammatory cytokines such as IL-10 and TGF-β have been shown to 
counteract the disrupting effects of IFN-γ and TNF-α, allowing better barrier function.  
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Table 1. Effects of inflammatory cytokines on intestinal barrier (adapted from Lallès, 2010) 
Cytokine Source Barrier function
1
 TJ changes Intra-cellular 
signalling
2
 
IFN-γ Lymphocytes, dendritic 
cells, monocytes 
TEER (-) PCP (+) Pinocytosis of TJ 
proteins (occludin, 
claudin); claudin-2 (-) 
Rho kinase, MLC 
phosphorylation 
TNF-α Activated lymphocytes 
and macrophages 
TEER (-) PCP (+) TJ strand numbers and 
depths (-) 
NF-kB, MLCK, 
PKA 
IL-1β Various immune-
modulatory cells 
TEER (-) PCP (+) Occludin (-) NF-kB, MLCK 
IL-10 TReg cells TEER (+) PCP (-) Protective against 
barrier and TJ changes 
induced by IFN- γ 
 
TGF-β TReg cells, epithelial 
cells 
TEER (+) PCP (-) Claudin-1 (+) ERK or PKC 
1 
TEER = trans-epithelial electrical resistance; PCP = para-cellular permeability. 
2
 ERK = extracellular signal-related kinase; MLC = myosin light chain; MLCK = MLC kinase; NF-kB = 
nuclear factor kappa B; PKA = protein kinase A; PKC = protein kinase C; Rho kinase = Ras homolog 
kinase. 
(+) increased; (-) decreased 
 
 
Figure 3 schematically shows the immunoregulatory responses that occur at the TJ 
level in order to maintain intestinal homeostasis (Turner, 2009). When a minor barrier 
defect allows bacterial products or dietary antigens to cross the epithelium and 
penetrate the lamina propria, it can lead to disease onset. If the luminal material is 
sensed by antigen-presenting cells (APCs) that drive the differentiation of effectors T 
helper cells (TH1 and TH2), disease can occur. In this case, APCs and TH1 cells can 
secrete IFN-γ and TNF-α that ‒ acting at the TJ level ‒ can increase epithelial 
permeability and allow further flux of bacterial products and antigens, thus amplifying 
the inflammatory status. In addition, IL-13 released by TH2 cells can enhance the flux 
of small solutes by altering the structure of claudin-2‒assembled pores. On the 
contrary, homeostasis can prevail if APCs direct the differentiation of regulatory T cells 
(TReg), that can be stimulated by TGF-β and retinoic acid produced by epithelial cells. 
TReg cells can secrete IL-10 and TGF-β to switch-off pro-inflammatory action of T 
helper cells and restore mucosal homeostasis. Therefore, the final outcome is strictly 
dependent on the fine balance between pro-inflammatory and immunoregulatory 
responses. Excessive responses to pro-inflammatory signals, insufficient IL-10 
production, or inadequate immune tolerance to luminal antigens or microbial 
compounds can favor the inflammatory process, thus underlining that ‒ along to a 
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defective epithelial barrier ‒ a susceptible host is required for homeostasis disruption 
and disease outbreak (Turner, 2009). 
 
 
Fig. 3. Inflammatory cytokines and tight junctions regulate mucosal homeostasis 
(from Turner, 2009) 
 
Defective barrier function and altered inflammatory responses are, for example, at the 
basis of several human intestinal inflammatory pathologies, such as inflammatory 
bowel disease (IBD), both Crohn’s disease and ulcerative colitis, coeliac disease (CD), 
and irritable bowel syndrome (IBS). 
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WEANING IN PIGS 
Weaning is widely accepted as the most significant and stressful phase in the pig’s life 
because of marked intestinal, nutritional, immunological and behavioral changes that 
cause high incidence of intestinal disturbances and reduced growth performance. This 
“growth check” along with low voluntary feed intake after weaning are major 
limitations for enhanced efficiency in pig production (Pluske et al., 1997). 
The weaning process is considered multi-factorial since pigs are subjected to several 
stressors (social, psychological, environmental, and nutritional) such as the separation 
from the sow, mixing with pigs from different litters, and social hierarchy stress, the 
different physical environment, the increased exposure to pathogens and dietary 
antigens, the nutritional change from highly digestible and palatable liquid milk to solid 
dry diet less digestible and palatable. In order to be productive and efficient, the piglet 
should rapidly adapt to the new conditions, otherwise poor growth and even mortality 
can occur (Campbell et al., 2013). 
During weaning the gastro-intestinal tract undergoes a series of structural and 
functional changes that, together with the immunological immaturity, are responsible 
for higher susceptibility to infections and intestinal disorders, among all the so-called 
post-weaning diarrhea (PWD), usually associated with proliferation of enterotoxigenic 
E.coli (ETEC). Although the small intestine is the part of the GIT most affected by 
weaning, some relevant changes take place also in the stomach during weaning. In 
weaning piglets gastric pH has been shown to be higher compared to sow-reared pigs, 
probably because of a lower acid secretion capacity of the stomach mucosa along with 
a reduction in lactic acid production from milk-derived lactose. According to Heo and 
coworkers, this high gastric pH can, in part, contribute to the susceptibility of piglets to 
enteric infections because a higher number of bacteria can pass into the small intestine, 
being less effective the “gastric acid barrier” usually bactericidal for many pathogens 
(including E.coli). In addition, weaning also reduces gastric motility, and gastric stasis 
has been reported in early-weaned piglets as a contributing factor for PWD (Heo et al., 
2013). 
The main changes occur in the small intestine and involve both structure and function. 
The morphological transformations include a reduction in villous height (villous 
atrophy) and an increase in crypt depth (crypt hyperplasia), probably because of an 
increased rate of cell loss and cell production, and resulting in reduced villous height : 
INTRODUCTION 
CHAPTER 1 
18 
crypt depth ratio compared to unweaned pigs. These structural changes are more 
evident when pig are weaned earlier at 14 days of age rather than later at 28 days 
(Pluske et al., 1997). In addition, a modification in the shape of the villi occur, from the 
longer, finger-like villi of newborn and suckling piglets, to the wider tongue or leaf-like 
villi of weaned pigs. These structural changes are generally associated with a temporary 
decrease in the digestive and absorptive capacity of the small intestine. The activity of 
brush-border enzymes such as lactase and sucrase have been found to be reduced 
regardless of whether creep food was offered before weaning or not. On the contrary, 
increases in carbohydrases such as maltase and glycoamylase are likely due to a 
substrate induction of these enzymes by solid diet (Pluske et al., 1997). As a 
consequence of the reduced digestive capacity, along with low feed intake, at weaning 
there is a drop in the metabolisable energy (ME) intake and, as summarized by Le 
Dividich and Herpin, a period of 3-4 weeks after weaning is required for the pig to 
restore the same metabolisable energy intake of the milk diet (Le Dividich & Herpin, 
1994). Moreover, weaning results in a reduction in the small intestine absorptive 
capacity of fluids, electrolytes, and malabsorption of nutrients that can contribute to the 
development of osmotic diarrhea because of the high amount of nutrients in the 
hindgut. In fact, in the large intestine weaning can cause a transient reduction in 
absorptive ability of the colon thus resulting in diarrhea since fluid loss exceeds fluid 
net absorption (Heo et al., 2013). In addition, such amount of undigested nutrients 
(particularly proteins) can favor microbial fermentations, overgrowth of bacteria such 
as coliforms and proteolytic clostridia, and consequent production of potentially 
harmful fermentation by-products. 
It is common for pigs to develop the so-called PWD characterized by frequent loss of 
watery faeces during the first 2 weeks after weaning. PWD is generally associated with 
proliferation in the small intestine and faecal shedding of a great number of β-
haemolitic enterotoxigenic E.coli (ETEC), so that it is also called post-weaning 
colibacillosis. Several serotypes of ETEC exist, with specific sets of virulence genes 
coding for fimbriae and toxins. ETEC fimbriae are required for adhesion and stable 
colonization of the small intestine mucosa, since they attach to glycoprotein receptors 
on the brush-border surface of villous enterocytes. Once attached to the host cell, 
bacteria can deliver the enterotoxins such as the heat-lable toxin and the heat-stable: 
these toxins activate cyclic guanosine monophosphate (cGMP) and cyclic adenosine 
monophosphate (cAMP) systems respectively, thus inducing an increased secretion of 
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sodium, chloride and hydrogen carbonate ions into the lumen, and a reduced absorption 
of salts and liquid, respectively (Heo et al., 2013). As a result of the hypersecretion of 
water and electrolytes in the small intestinal lumen that exceeds the absorptive capacity 
of the colon, diarrhea, dehydration, reduced feed intake, reduced nutrient digestibility, 
reduced growth and even death can occur. Several studies have been conducted in order 
to elucidate the mechanisms of adhesion to intestinal cells by ETEC and cellular 
responses (in vitro studies), and to investigate possible dietary interventions to 
minimize ETEC-induced PWD (in vivo trials with oral E.coli challenge models). In this 
regard, the major limitation of these E.coli challenges relies in the great discrepancy 
between the clean and hygienic environment of the research facilities where these 
studies are conducted and the commercial piggeries, where pigs are subjected to 
multiple stressors. In addition, many factors should be considered such as age, body 
weight and health status of animals, dose concentration and serotype of ETEC, animal 
susceptibility and receptors profile for ETEC adhesion. In addition to the 
hypersecretory effect, ETEC infection also affect the epithelial barrier function 
increasing para-cellular permeability and reducing trans-epithelial electrical resistance 
either through contraction of the actomyosin ring or occludin dephosphorylation and 
ZO-1 redistribution (Kim et al., 2012). 
Other extremely important changes that occur during weaning are the immunological 
changes. At weaning, the intestinal immune system of the piglet is still immature and 
the withdrawal of the sow’s milk deprives the piglet of IgA and bioactive compounds 
(as well as growth factors and hormones) thus increasing the susceptibility to enteric 
diseases. The immune immaturity impairs the ability of the piglet to develop an 
adequate response against pathogens and to tolerate dietary antigens. For example, a 
transient reduction in the response of intra-epithelial lymphocytes to mitogens, as well 
as a transient hypersensitivity to dietary soy protein have been reported in weaning 
piglets (Heo et al., 2013). Weaning has been described to induce intestinal 
inflammation in several species: increased number of TH1 and TH2 lymphocytes in 
mice; activation of the mucosal immune system, villous atrophy and cypt hyperplasia in 
rats. In pigs, McCracken and colleagues reported increased T helper and T cytotoxic 
lymphocytes in jejunal villi 2 days post-weaning and proposed post-weaning anorexia, 
along with consequent gut changes, as the major contributor to local intestinal 
inflammation, since pre-weaning values of inflammatory cells were achieved upon 
resumption of feed intake (McCracken et al., 1999). In addition, the intestinal 
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inflammatory response has been shown to be early and transient (occur within 2 days 
post-weaning and it is repaired by day 8), characterized by the up-regulation of pro-
inflammatory cytokines genes, including TNF-α, IL-1β, and IL-6 (Pié et al., 2004). 
This hyper-activation of the intestinal inflammatory system can negatively affect TJ 
architecture and permeability, thus leading to impaired epithelial barrier function and 
increasing the risk of intestinal disorders. Therefore, an adequate modulation of the 
intestinal inflammation is essential to prevent weaning-associated intestinal diseases. 
Moreover, as described by Smith and coworkers, the intestinal damage induced by 
weaning can have long-term consequences on the intestinal barrier function and 
intestinal health: comparing different weaning ages, the authors found that early 
weaning (from 15 to 21 days of age) resulted in huge impairment in the barrier function 
as suggested by reduced jejunal trans-epithelial electrical resistance and increased para-
cellular fluxes across the mucosa, compared to the values of late-weaned piglets (from 
23 to 28 days of age). This disrupting effect was observed at 5 weeks of age and was 
still appreciable at 9 weeks, thus indicating that stress occurring at weaning can alter 
the development of the mucosal barrier and have long-lasting effects on the intestinal 
health (Smith et al., 2010). 
 
Nutritional strategies to control weaning 
In order to assist the weaning-associated growth retard, antibiotics have long been used 
in pig industry as growth promoters, based on the modulatory effects on intestinal 
microbiota, including both commensal and pathogenic bacteria. However, increasing 
concerns about the risk of antibiotic resistance in humans, led the EU to ban the use of 
in-feed antibiotic growth promoters (AGP) in 2006. Since then, a large number of AGP 
alternatives, including feed additives and dietary interventions, have been studied and 
proposed.  
The first goal of a nutritional strategy alternative to using in-feed antibiotic is to 
minimize intestinal dysfunction associated with intestinal changes, intestinal barrier 
disruption and enteric pathogens overgrowth. For this reason, the main targets of 
interventions are those factors that influence PWD through reducing pathogen 
proliferation and maintaining intestinal barrier function, such as dietary protein 
modulation and dietary carbohydrate modulation. Dietary protein level is critical 
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because at weaning piglet’s capacity to digest proteins is low and dependent on the 
pancreatic and brush-border proteolytic enzymes not fully developed. Undigested 
proteins can be utilized as substrates for bacterial fermentations in the distal part of the 
small intestine and in the large intestine, leading to overgrowth of proteolytic bacteria 
(including E.coli and Clostridiaceae family) at the expense of saccharolytic and 
butyrate-producers microbes, pathogen proliferation, and production of potentially 
toxic compounds (ammonia, amines, volatile phenols and indoles) with negative 
consequences on the epithelial integrity (Piva et al., 1996). Therefore, low-protein diets 
are recommended rather than high-protein diets to maintain better intestinal health at 
weaning, provided that similar digestible energy is given and adequate levels of 
essential aminoacids are supplemented (Heo et al., 2013). The dietary non-starch 
polysaccharides (NSPs) modulation as source of carbohydrates in diets of weaning 
piglets is based on the different effect of soluble and insoluble NSPs. Soluble NSPs 
have been found to increase digesta viscosity, decrease digesta transit time and nutrient 
digestibility, consequently allowing the proliferation of ETEC, main responsible of 
PWD. On the contrary, insoluble NSPs are known to decrease digesta retention time 
and small intestinal pathogen proliferation, thus being recognized as a dietary 
ingredient to reduce post-weaning colibacillosis in weaned pigs (Kim et al., 2012). 
Along with the abovementioned modulations of dietary components, other alternatives 
to antimicrobial compounds in diets for weaning piglets have been proposed, including 
supplementation with probiotics (lactic acid-bacteria and yeasts), prebiotics (such as 
non-digestible oligosaccharides, electively fermented by “positive” bacteria), 
exogenous enzymes (to improve digestive functions and reduce viscosity of the 
digesta), organic acids (with acidifying and anti-microbial properties against 
pathogens), and essential trace elements (zinc and copper). 
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Intestinal health is essential for the health of the body since the gastro-intestinal mucosa 
is the main site of interaction with the external environment, as well as the major area 
colonized by the microbiota. Intestinal health relies on proper barrier function, provided 
by epithelial integrity and related mechanisms of protection (mucous layer, tight 
junctions, immune and inflammatory system). 
In pigs, during the weaning transition, intestinal inflammation and intestinal barrier 
integrity play a crucial role in regulating intestinal health and, consequently, pig’s 
health, growth and productivity. 
The aim of the project was to assess the impact of the diet on the intestinal health of 
weaning piglets with particular reference to the intestinal inflammatory status and 
epithelial integrity. 
Therefore, a series of in vivo experimental studies were conducted in order to evaluate 
different nutritional strategies to control intestinal inflammation in weaning piglets: 
- Zinc trial No. 1: the effect of zinc oxide, fed either free or microencapsulated, 
was investigated on the expression of inflammation markers and tight junctions 
proteins in the ileum of weaning piglets. 
- Zinc trial No. 2: the effect of zinc oxide, fed either free or microencapsulated, 
was assessed on growth performance and ileal architecture of weaning piglets. 
- Tributyrin trial: the effect of tributyrin, as dietary source of butyric acid, was 
evaluated on growth performance, intestinal architecture and inflammatory 
cytokines and tight junctions proteins expression in weaning piglets. 
- Organic acids and nature-identical compounds trial: the effect of a mixture of 
organic acids and nature-identical compounds was investigated on intestinal 
barrier integrity and inflammatory status in early-weaned piglets. 
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ABSTRACT 
Aim of this study was to investigate the expression of inflammation markers and tight 
junction proteins in the ileum of weaning piglets fed with low doses of 
microencapsulated ZnO (mZnO) in comparison with a pharmacological dose of ZnO. 
Twenty-four piglets weaned at 28 d were divided in 4 groups: (1) control; (2) free ZnO, 
2,850 mg Zn/kg diet; (3) mZnO-300, 140 mg Zn/kg diet; (4) mZnO-800, 380 mg Zn/kg 
diet. After 14 days, piglets were killed and ileal samples were collected for cytokines 
and tight junction components analysis at mRNA and protein level. Both groups 
receiving mZnO tended to have a reduced mRNA expression of IL-6 compared to both 
control and ZnO group (−25%, P = 0.10) and also a numerically lower level of tumor 
necrosis factor-α (TNF-α) mRNA (−25%, P = 0.18). In mZnO-800 group interferon-γ 
(IFN-γ) mRNA was the lowest (P = 0.02), and the protein tended to be lower than in 
ZnO group (P = 0.08). Both free ZnO and mZnO reduced TNF-α protein level (P < 
0.0001). Compared to control and ZnO group, mZnO-800 increased occludin protein 
level (2–4 fold, respectively; P < 0.001), zonula occludens-1 protein level (1.3–1.5 fold, 
respectively; P < 0.001), and claudin-1 mRNA level (1.7–2.4, respectively; P = 0.01). 
The results suggest that ZnO released from a lipid matrix was available in the ileum of 
piglets where it positively impacted inflammatory status and, consequently, epithelial 
integrity via tight junction proteins. Therefore, microencapsulated ZnO is proposed as 
an effective and environmentally safe alternative to pharmacological ZnO. 
Keywords: inflammatory cytokines, microencapsulated zinc oxide, piglets, tight 
junctions. 
 
INTRODUCTION 
The weaning phase represents a dramatic challenge to intestinal health due to various 
type of stressors (separation from sow, change of environment and feeding, etc.) and is 
accountable for several physiological, anatomical, and immunological changes that are 
responsible for a decrease in the absorptive surface of the mucosa, an impaired barrier 
and protection against environmental challenges, and, as a consequence, an increased 
susceptibility to infections. In particular, within the gut barrier components, the 
epithelial layer plays a central role in maintaining the integrity and health of the 
mucosa, as a leaky gut is the main cause of infections and reduced performance (Lallès, 
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2010). Mucosal integrity is essential for gut barrier function, as first line of protection 
against harmful exogenous agents, such as pathogens, bacterial products, dietary 
antigens and toxicants. Tight junctions (TJ) are the most important structures of the gut 
barrier, linking the cytoskeleton and actin filaments of two adjoining cells, and 
regulating the so-called para-cellular permeability. Several extra-cellular molecules 
continuously modulate TJ status, among which inflammatory cytokines are considered 
as major mediators of intestinal epithelial permeability (Lallès, 2010). Stress factors 
associated to weaning can compromise the intestinal barrier function through mucosal 
damage and alteration of TJ structure. These dramatic changes in barrier integrity and 
permeability occur mainly in the small intestine and are both acute and long-lasting 
alterations (Boudry et al., 2004; Smith et al., 2010). 
In-feed zinc oxide (ZnO) has been used extensively to help reducing the symptoms of 
the post-weaning phase and to prevent diarrhea, after in the late 80’s Poulsen described 
its beneficial properties (Poulsen, 1989). Due to ZnO low relative bioavailability and 
the low pig feed intake, the use of high supplemental ZnO, ie 2,500‒3,000 mg/kg, 
appears to be essential to provide the amount of Zn necessary to exploit its beneficial 
effect, but increasing concerns on heavy metals excretion in manure in Europe, though, 
had imposed caution in the use of ZnO at high doses (EU, 2003). 
Therefore, in this study we aimed to assess whether lipid microencapsulation could 
allow to reduce the inclusion of ZnO in the feed to levels substantially lower than the 
2,500–3,000 mg/kg currently in use, and we did so by measuring the effects of 
microencapsulated ZnO on inflammatory cytokines and intestinal integrity markers 
such as tight junctions proteins.  
 
MATERIALS AND METHODS 
The study was conducted at the research facilities of the Research Centre for Animal 
Production and Environment (CERZOO), which is a Good Laboratory Practices-
certified facility and operates according to the procedure of animal protection and 
welfare (Directive 86/609/EEC). 
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Experimental Design and Sample Collection 
Twenty-four pigs (Landrace × Large White, barrows and gilts, 7.17 (SE 0.14) kg of 
BW) weaned at 28 days of age were divided into 4 experimental groups (6 animals per 
group) and fed ad libitum either the basal diet (control, providing Zn at 50 mg/kg), or 
the control diet added with ZnO at 3,000 mg/kg (fZnO, providing Zn at 2,850 mg/kg), 
or the control diet supplemented with microencapsulated ZnO (mZnO) providing Zn at 
140 mg/kg or 380 mg/kg (mZnO-300 and mZnO-800, respectively). Basal diet was 
formulated to meet or exceed requirements recommended by the National Research 
Council (NRC, 1998), (Ingredients, as-fed basis: corn meal 40%, soybean meal (44%) 
19.81%, barley meal 20.34%, wheat bran 5%, milk serum 8%, soybean oil 1.37%, 
calcium carbonate 1%, potato extract 2.5%, dicalcium phosphate 0.6%, Lys HCl 
0.53%, NaCl 0.35%, L-Thr 0.21%, DL-Met 0.22%, L-Trp 0.07%). The health status of 
animals was monitored throughout the study. After 14 days pigs were killed and 
intestinal samples were collected. Ileal samples, 10 cm from the ileo-cecal valve, were 
cut longitudinally to expose the mucosa and washed with PBS to remove mucus and 
digesta. Then the mucosa was scraped gently with a glass slide, vacuum-packed, 
immediately frozen in liquid N2 and stored at −80°C until gene and protein expression 
analysis was conducted. 
Inflammatory Cytokines and TJ Components Gene Expression Profiling 
Ileal scrapings were disrupted by grinding in liquid N2 with mortar and pestle, then 
homogenized using TissueLyser (Qiagen, Hilden, Germany). Total RNA was isolated 
from ileal mucosa scraping using RNeasy Mini Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. Genomic DNA contamination was 
removed by treatment with deoxyribonuclease (RNase-Free DNase Set, Qiagen, 
Hilden, Germany). RNA yield and quality were determined spectrophotometrically 
using A260 and A280 nm measurements. All samples showed A260:A280 ratio of 1.8–2.0. 
A total of 1 µg of RNA was reverse-transcribed with iScript cDNA Synthesis Kit (Bio-
Rad Laboratories Inc., Hercules, CA) according to the manufacturer’s instructions. 
Resulting cDNA was quantified with Quant-iT Oligreen ssDNA Assay (Life 
Technologies Italia, Monza, Italy) to normalize the quantity of cDNA template used for 
amplification by real-time PCR. Real-time PCR was performed using iCycler Thermal 
Cycler system and SybrGreen Supermix (Bio-Rad Laboratories Inc., Hercules, CA). 
Thermocycling protocol included initial denaturation for 1 min and 30 s at 95°C, 40 
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cycles of denaturation at 95°C for 15 s followed by 30 s of annealing and extension at 
60°C. After amplification, all samples were subjected to a melt curve analysis, with a 
slow heating from 55 to 95°C with a rate of 0.5°C/s to validate absence of non-specific 
products. 
Gene expression was normalized using two housekeeping genes coding for portions of 
porcine ribosomal subunit 60S, such as ribosomal protein L35 (RPL35) and ribosomal 
protein L4 (RPL4). Average threshold cycle (CT) was determined for each gene of 
interest (GOI), and geometric average was calculated for housekeeping genes (HKs), 
assuming CT as number of cycles needed to reach a fixed arbitrary threshold. Delta CT 
was calculated as CT GOI−CT HKs, then a modification of the 2
–ΔΔC
T method was used 
to analyze the relative expression (fold changes), calculated relative to the control 
group (Livak and Schmittgen, 2001). 
The sequences, expected product length, accession number in the EMBL 
database/GenBank and references of porcine primers are shown in Table 1. Primer 
oligonucleotides for claudin-1, tumor necrosis factor-α (TNF-α), and interferon-γ 
(IFN-γ) were designed using PrimerQuest software (IDT, Integrated DNA 
Technologies, www.idtdna.com). Primers were obtained from Life Technologies (Life 
Technologies Italia, Monza, Italy). 
ELISA Quantification of Inflammatory Cytokines 
Inflammatory cytokines protein levels were analyzed using commercial ELISA kit 
specific for porcine cytokines (Quantikine ELISA, R&D Systems, Inc., Minneapolis, 
MN). Before analysis, ileal mucosa scrapings were disrupted by grinding in liquid N2 
with mortar and pestle, added with lysis buffer (10 mM Tris-HCl, 1 mM-EDTA, 0.5%-
Triton X100) and homogenized using TissueLyser (Qiagen, Hilden, Germany). 
Analyses were performed according to manufacturer’s instructions. Results refer to 
picograms of cytokine per 100 mg of tissue (pg/100 mg). 
TNF-α and TJ Components Western Blot Quantification 
TNF-α, occludin and zonula occludens-1 (ZO-1) protein levels were analyzed by 
Western blot. Briefly, mucosal scraping of ileum (approximately 1 g) from each animal 
were homogenized in a 2 mL solution containing ice-cold lysis buffer (50 mM Tris- 
HCl, 150 mM-NaCl, 0.1%-SDS, 0.5%-sodium deoxycholate, 1%-NP-40, pH 7.4) 
supplemented with a protease inhibitor cocktail (EuroClone, S.p.A., Milano, Italy). 
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Table 1. Primers used for gene expression analysis by Real-Time PCR 
Gene Primer Sequence (F and R
1
; 5’ → 3’) Product 
lenght 
(bp) 
Product 
Tm
2
 
(°C) 
Accession 
number 
Reference 
ZO-1
3
 F: GAGTTTGATAGTGGCGTT 
R: GTGGGAGGATGCTGTTGT 
298 87.5 XM_00335
3439.2 
Zhang and 
Guo, 2009 
Occludin F: ATCAACAAAGGCAACTCT 
R: GCAGCAGCCATGTACTCT 
157 83 NM_00116
3647.2 
Zhang and 
Guo, 2009 
Claudin-1 F: TCCAGTGCAAAGTCTTCGACTCCT 
R: ATGCCAACAGTGGCCACAAAGATG 
121 85.5 NM_00124
4539.1 
Present 
study 
IL-6 F: AGCAAGGAGGTACTGGCAGAAAACAAC 
R: GTGGTGATTCTCATCAAGCAGGTCTCC 
110 83.5 NM_21439
9.1 
Zannoni et 
al., 2012 
IL-10 F: CGGCGCTGTCATCAATTTCTG 
R: CCCCTCTCTTGGAGCTTGCTA 
89 85 NM_21404
1.1 
Duvigneau 
et al., 2005 
TNF-α4 F: GCCCACGTTGTAGCCAATGTCAAA 
R: GTTGTCTTTCAGCTTCACGCCGTT 
99 87 NM_21402
2.1 
Present 
study 
IFN-γ5 F: GGCCATTCAAAGGAGCATGGATGT 
R: TGAGTTCACTGATGGCTTTGCGCT 
149 83.5 NM_21394
8.1 
Present 
study 
RPL35
6
 F: AACCAGACCCAGAAAGAGAAC 
R: TTCCGCTGCTGCTTCTTG 
146 87.5 NM_21432
6.2 
Alexander 
et al., 2012 
RPL4
7
 F: CAAGAGTAACTACAACCTTC 
R: GAACTCTACGATGAATCTTC 
122 84 XM_00312
1741.3 
Alexander 
et al., 2012 
1
 F = forward primer, R = reverse primer 
2 
Tm = melting temperature 
3
 ZO-1 = zonula occludens-1 
4
 TNF-α = tumor necrosis factor-α 
5
 IFN-γ = interferon-γ 
6
 RPL35 = ribosomal protein L35 
7
 RPL4 = ribosomal protein L4. 
 
The homogenates were centrifuged at 10,000 × g at 4°C for 5 min to remove all 
insoluble material. The supernatant was collected and the protein concentration of each 
sample was determined using a bicinchoninic acid (BCA) protein assay kit (Pierce, 
Thermo Fisher Scientific Inc., Rockford, IL). Total proteins (50 μg) were loaded either 
onto 10% SDS gels for occludin and TNF-α or onto 6% SDS gel for ZO-1, and 
subsequently electro-transferred onto nitrocellulose membranes. After blocking with 
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5% non-fat milk in Tris-buffered saline for 1 h at room temperature (RT), membranes 
were incubated for 2 h at RT with the following primary antibodies: anti-occludin 
(1:500; Life Technologies Italia, Monza, Italy), anti-ZO-1 (1:500; Life Technologies 
Italia, Monza, Italy), anti-TNF-α (1:200; Abcam, Cambridge, United Kingdom) and 
anti-actin (1:2000; Sigma-Aldrich S.r.l., Milan, Italy). Subsequently, they were washed 
and incubated for 1 h at RT with a horseradish peroxidase-conjugated secondary 
antibody (1:5000; Bio-Rad Laboratories Inc., Hercules, CA). The blots were developed 
using the ECL system (GE Healthcare Europe, GmbH, Milan, Italy): 
immunoreactivities were detected by chemiluminescence autoradiography according to 
the manufacturer's instructions. The optical densities of the protein bands of interest 
were determined densitometrically using the Scion Image software (Scion Corporation, 
Frederick, MD) and the values were normalized to actin levels. 
 
Statistical Analysis 
Animals were grouped in a completely randomized design and data were analyzed with 
one-way ANOVA, followed by Tukey post hoc test (Graph Pad Prism 5 version 5.03; 
GraphPad Software, Inc, San Diego, CA). The pig was the experimental unit. 
Differences were considered significant at P < 0.05 and trends for 0.05 < P ≤ 0.1. 
 
RESULTS 
Inflammatory Cytokines Profiling 
The mRNA and protein levels of inflammatory cytokines in ileal mucosa are presented 
in fig. 1 and 2 respectively. Groups treated with microencapsulated ZnO tended to have 
reduced mRNA expression of IL-6, compared to both control and free ZnO groups (‒
25%, P = 0.10) and also had a numerically lower expression of TNF-α mRNA (‒25%; 
P = 0.18). mZnO-800 group had the lowest expression of IFN-γ and significantly lower 
than mZnO-300 group (P = 0.02). No effects were observed in IL-10 gene expression. 
IFN-γ and IL-10 protein content tended to be greater in fZnO group and mZnO-300 
group than in control and mZnO-800 groups (P = 0.08). IL-6 protein content was not 
affected by the treatments. Both free ZnO and mZnO significantly reduced TNF-α 
expression compared to control group (P < 0.0001). 
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Fig. 1. Gene expression of inflammatory cytokines in ileal mucosa. 
Data are expressed as means (n = 6) and SEM represented by vertical bars.  
a,b
 Mean values with unlike superscript letters were significantly different (P < 0.05). 
Control = basal diet providing Zn at 50 mg/kg; fZnO = basal diet + free ZnO providing Zn at 2,850 
mg/kg; mZnO-300 = basal diet + microencapsulated ZnO providing Zn at 140 mg/kg; mZnO-800 = basal 
diet + microencapsulated ZnO providing Zn at 380 mg/kg. 
A modification of the 2
–ΔΔC
T method was used to analyze the relative expression (fold changes), 
calculated relative to the control group (control), (Livak & Schmittgen, 2001). 
 
 
Fig. 2. Protein expression of inflammatory cytokines in ileal mucosa. 
Data are expressed as means (n = 6) and SEM represented by vertical bars. 
a,b
 Mean values with unlike superscript letters were significantly different (P < 0.05). 
Control = basal diet providing Zn at 50 mg/kg; fZnO = basal diet + free ZnO providing Zn at 2,850 
mg/kg; mZnO-300 = basal diet + microencapsulated ZnO providing Zn at 140 mg/kg; mZnO-800 = basal 
diet + microencapsulated ZnO providing Zn at 380 mg/kg. 
Data refer to picograms of cytokine per 100 milligrams of tissue (pg/100 mg) measured using ELISA 
method. 
* Tumor necrosis factor-α (TNF-α) expression was measured by Western blot and data refer to arbitrary 
unit (AU) of protein expression. 
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TJ Components Profiling 
Figure 3 summarizes the results from gene and protein expression analysis of TJ 
components. Occludin gene expression was the lowest in mZnO-800 group and 
significantly lower than in mZnO-300 group (2 fold lower; P = 0.04). ZO-1 expression 
was not affected by the treatments. Claudin-1 gene expression was 1.7–2.4 greater in 
mZnO-800 compared with control and fZnO, respectively (P = 0.01). Overall, mZnO-
300 group tended to have intermediate values between fZnO and mZnO-800. 
Both free ZnO and mZnO treatments had significantly higher occludin protein level 
than control group. Among the treatments, mZnO-800 group showed the highest level 
of occludin and was 2–4 fold greater than control and fZnO, respectively (P < 0.001). 
ZO-1 protein level was significantly greater in mZnO-800 group compared to both 
control and fZnO groups (1.5–1.3 fold respectively), whereas mZnO-300 had 
intermediate values (P = 0.01). 
 
 
Fig. 3. Gene and protein 
expression of TJ components in 
ileal mucosa. 
 
(A) and (B) show gene and protein 
expression, respectively. Data are 
expressed as means (n = 6) and SEM 
represented by vertical bars. 
a,b,c
 Within the same gene or protein, 
mean values with unlike letters were 
significantly different (P < 0.05). 
Control = basal diet providing Zn at 50 
mg/kg; fZnO = basal diet + free ZnO 
providing Zn at 2,850 mg/kg; mZnO-
300 = basal diet + microencapsulated 
ZnO providing Zn at 140 mg/kg; mZnO-
800 = basal diet + microencapsulated 
ZnO providing Zn at 380 mg/kg . 
For gene expression, a modification of 
the 2
–ΔΔC
T method was used to analyze 
the relative expression (fold changes), 
calculated relative to the control group 
(control), (Livak & Schmittgen, 2001). 
For protein expression, data refer to 
arbitrary unit (AU) of protein expression 
measured using Western blot. 
ZO-1 = zonula occludens-1; AU = 
arbitrary unit. 
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DISCUSSION 
High levels of in-feed zinc oxide (2,500−3,000 mg/kg) are widely used to control post-
weaning diarrhea and improve growth performance of pigs (Zhang and Guo, 2009; 
Pluske, 2013; Heo et al., 2013) and numerous mechanisms of action of ZnO have been 
proposed so far. Previous researches have reported that inorganic Zn as ZnO can 
increase the expression of antimicrobial peptides in the small intestine (Wang et al., 
2004), exert positive effects on the stability and diversity of the microbiota (Katouli et 
al., 1999), prevent bacterial adhesion to the epithelium (Roselli et al., 2003), modulate 
the expression of genes encoding stress response proteins in enterocytes (Sargeant et 
al., 2011), improve intestinal growth through increasing insulin-like growth factor-I and 
insulin-like growth factor-I receptor expression in the small-intestinal mucosa (Li et al., 
2006), and reduce electrolyte secretion from enterocytes in vitro (Carlson et al., 2006). 
Moreover, ZnO is supposed to positively act on mucosal barrier integrity by enhancing 
the expression of TJ proteins and reducing the intestinal permeability of weaning 
piglets (Zhang and Guo, 2009). 
Zinc is essential to more than 300 enzymatic reactions among which it seems to be 
central in inhibiting the apoptotic process, and in protecting cells from death (Faa et al., 
2008). Moreover, Zn is critical in the development and function of the immune system, 
including cytokine production, and it regulates the intestinal barrier integrity. 
Impairments in Zn homeostasis have in fact been observed in human patients suffering 
inflammatory diseases like inflammatory bowel disease (IBD), irritable bowel 
syndrome (IBS) and Crohn’s disease where the altered permeability of the stressed gut 
mucosa is the cause of a malfunction at the basis of modifications in Zn homeostasis 
(Faa et al., 2008). 
The central role of Zn as an anti-inflammatory agent is described by numerous 
researches. Roselli et al. reported ZnO (at concentration of 16.3 and 81.4 mg/L) to 
reduce and prevent enterotoxigenic E. coli adhesion and internalization, and reduce 
inflammatory cytokine expression on Caco-2 cells (Roselli et al., 2003). Similarly, 
Sargeant et al. showed that ZnO reduced the inflammatory response of porcine 
epithelial IPEC-J2 cells to enterotoxigenic E.coli, probably through up-regulated heat 
shock proteins and consequent inhibition of nuclear factor-kappa B (NF-KB) pathway 
(Sargeant et al., 2011). The reduction of inflammatory cytokines expression induced by 
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ZnO has been proposed as molecular basis for protection of epithelial integrity by 
preventing TJ disruption (Roselli et al., 2003).  
Results from our study confirm previous findings on the anti-inflammatory properties 
of Zn. In fact, regardless of the treatment, ZnO impacted the expression of 
inflammatory cytokines and in particular of TNF-α and IFN-γ which in turn regulated 
the expression of epithelial integrity proteins. Both cytokines have in fact a 
preponderant role in altering the intestinal permeability by acting on the TJ complex. 
IFN-γ, which had the lowest expression in pigs fed with microencapsulated ZnO at 800 
mg/kg (mZnO-800) affected occludin expression: occludin mRNA was the lowest in 
mZnO-800 group, but the protein amount in the same group was the highest, thereby 
indicating a negative feedback regulation of gene expression. The mechanism by which 
IFN-γ would affect epithelial integrity is by causing macro-pinocytosis of occludin, a 
trans-membrane protein whose expression is correlated with enhanced barrier 
properties (Bruewer et al., 2005), and the lower the level of IFN-γ, the higher the 
occludin amount. 
TNF-α expression and protein content were numerically and significantly lower in all 
groups receiving supplemental ZnO compared to the control group. TNF-α has a dual 
effect on cell survival by either activating necrosis or apoptosis. While necrosis is 
induced by activation of NF-KB, the latter involves the caspase protein superfamily. It 
has been postulated that apoptosis of adjacent epithelial cells might contribute to the 
increase in permeability caused by the simultaneous action of TNF-α and IFN-γ (Al-
Sadi et al., 2009), and Zn has been shown to inactivate casapase-3 and, therefore, 
inhibit apoptosis (Perry et al., 1997). 
The role of other cytokines in modulating the intestinal permeability and integrity is 
still under investigation though it is known that IL-6, produced immediately after TNF-
α and IL-1β in the inflammation cascade, contributes to the worsening of permeability 
and an increase in para-cellular flux whereas anti-inflammatory IL-10 prevents 
disarrangement of TJ structure (Al-Sadi et al., 2009). In our study IL-6 and IL-10 were 
marginally affected by ZnO, regardless of the dose or source, and appeared to have a 
minor role compared to TNF-α and IFN-γ on the regulation of the TJ structure. 
Zonula occludens is a family of proteins of the TJ, and in particular ZO-1, along with 
occludin, has a pivotal role in maintaining the epithelial integrity. ZO-1, in fact, is a 
bridge connecting occludin and claudins to the β-actin filaments of the cell cytoskeleton 
(Fanning et al., 1998). In this study ZO-1 protein content was 1.5–2 fold greater in pigs 
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fed with the highest dose of mZnO compared to control and fZnO, respectively, 
whereas mZnO at 300 mg/kg had intermediate values. Also claudin-1 mRNA, another 
major protein of the TJ complex whose localization and expression is strictly connected 
to ZO-1, was up-regulated in pigs receiving the greatest dose of mZnO compared to the 
fZnO. These last results confirm the protective role of Zn from ZnO in preventing TNF-
α and IFN-γ-mediated increase in para-cellular permeability and alteration of TJ 
functionality, but, more importantly, suggest that Zn from microencapsulated ZnO 
might be more available than Zn from free ZnO. In fact, despite the anti-inflammatory 
effect could be generally attributable to Zn from ZnO, regardless of the source, the TJ 
protein structure was clearly modulated in a dose-treatment dependent way. The 
abundance of both occludin and ZO-1, as shown in fig. 3, was mZnO-800 > mZnO-300 
> fZnO > control, and it might be speculated that ZnO from microencapsulation was 
more available at ileal level than free ZnO. The relative bioavailability of Zn can vary 
substantially among different sources but, regardless of the source, pharmacological 
levels of ZnO seems to be critical to exert the beneficial and the growth promoting 
effect. Whether the efficacy is connected to a luminal or systemic effect remains 
unclear (Mavromichalis et al., 2000), but from this study it seems that an higher amount 
of Zn was available for the enterocyte in the ileum. Microencapsulation in a 
hydrogenated lipid matrix has been previously demonstrated to allow a slow release of 
active principles along the gut and prevent their complete disappearance upon entering 
the stomach (Piva et al., 2007; Grilli et al., 2010). ZnO in the stomach has a strong anti-
buffering capacity that might decrease acidic secretion and impair the digestive 
capacities of young animals (Lawlor et al., 2005). Moreover, low acidic environments, 
such as the stomach, can cause ZnO to dissociate, liberate Zn ions which, once passing 
to the more neutral intestinal environment, can react with water molecules and create 
Zn dihydroxide, an insoluble compound that does not deliver adequate amount of Zn. 
The encapsulation of ZnO in a lipid matrix allows to overcome these problems and 
delivers Zn to the ileum, the major site of intestinal immunological activity. 
Pharmacological levels of free ZnO had a milder effect on the expression of TJ proteins 
compared to microencapsulated ZnO, but we cannot exclude major effects upstream in 
the GI tract. In fact, Hu and colleagues showed that ZnO providing Zn at 2,250 mg/kg 
decreased the jejunal para-cellular permeability, decreased mRNA expression of pro-
inflammatory cytokines, and up-regulated jejunal TJ protein expression (Hu et al., 
2013). 
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In conclusion, lipid microencapsulation of ZnO allowed to reduce in-feed inclusion of 
ZnO by 6–15 times compared to pharmacological levels, allowing Zn to be released 
along the intestine and reach the ileum where it positively impacted the inflammatory 
status and ileal integrity. Therefore, microencapsulated zinc oxide is here proposed as 
an effective and environmentally safe alternative to pharmacological levels of ZnO. 
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ABSTRACT 
Aim of this study was to compare low doses of microencapsulated versus 
pharmacological level of ZnO in the diet of piglets on growth performance and ileal 
architecture. 144 weaned piglets, divided in 36 pens (n = 9), received a basal diet 
(control, Zn at 50 mg/kg) or the basal diet with ZnO at 3,000 mg/kg (free ZnO, fZnO), 
or with lipid microencapsulated ZnO providing Zn at 140 or 380 mg/kg (mZnO-300 
and mZnO-800, respectively). After 15 and 42 d, 6 pigs per group per time were 
euthanized to collect ileal mucosa for immunohistochemistry, histomorphology, and 
Na-dependent glucose transporter (SGLT-1) gene expression. Pigs BW and feed intake 
were recorded at 0, 7, 14 and 42 d and ADG and G:F were calculated. Data were 
analyzed with 1 way ANOVA. At d 14 the fZnO group had a 32% and 7% higher ADG 
and BW, respectively, and +54% G:F compared with control (P < 0.05), whereas 
mZnO-300 and mZnO-800 had intermediate values. At 42d both groups receiving 
microencapsulated ZnO had 9% higher BW than control and did not differ from fZnO 
group (P = 0.01). ADG was on average 24% higher for fZnO and mZnO-800 than the 
control (P = 0.05) and G:F was numerically higher in all treated groups compared with 
control group (+26%; P = 0.11). At 14 d, villi length in mZnO-800 pigs was 11% and 
8% higher than in control and fZnO, respectively (P < 0.01) and the villi:crypts ratio 
(V:C), as well as % of mitotic cells, were higher in all treated groups compared with 
control (P < 0.01). SGLT-1 gene expression was the lowest in mZnO-800 pigs. At 42d 
villi length and V:C ratio were the highest for fZnO compared with all of the other 
groups (+10% than control; P = 0.01). Mitotic cells were the highest in mZnO-800 
group compared with other groups (+3% compared with control and fZnO; P < 0.01), 
whereas SGLT-1 expression tended to be lower in mZnO-300 and mZnO-800 groups 
compared with control and fZnO (P = 0.06). Pigs receiving low doses of 
microencapsulated ZnO had performance comparable to those receiving 
pharmacological level of ZnO overall the post-weaning phase. Moreover, in the first 2 
weeks, microencapsulated ZnO improved the ileal architecture as reflected by the 
increased V:C ratio and the % of mitotic cells. The reduced SGLT-1 m-RNA 
abundance might suggest a reduced availability of glucose in the lumen of ileum, 
therefore suggesting a lower amount of undigested nutrients. 
Keywords: ileum, microencapsulation, piglet, SGLT-1, zinc oxide 
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INTRODUCTION 
The post weaning syndrome is a multi-factorial disease causing important economic 
losses in terms of mortality and medication costs. Gut anatomical and physiological 
changes are at the basis of the massive damage to the intestinal mucosa resulting in 
decreased absorptive capacity and disruption of the barrier function. An increased host 
susceptibility to E. coli has been often associated to the onset of the post weaning 
syndrome and the inclusion of 2,500‒3,000 mg/kg of ZnO to weaning diets has been 
generally accepted as a tool to prevent and smooth diarrhea, and improve feed intake 
and growth performance (Poulsen, 1989; Jensen-Waern et al., 1998; Sargeant et al., 
2010). The mode of action of ZnO, though, is still debated, and despite Zn deficiencies 
are not involved in E. coli pathogenesis, the effective dose of ZnO is well above the 
requirements. Nevertheless, the lack of association between plasmatic Zn and incidence 
of diarrhea has suggested a pathway independent from absorption (Patel et al., 2010; 
Sargeant et al., 2011). Also, the fact that the major part of ingested ZnO is excreted 
with the feces implies a direct effect on the gut rather than a systemic effect 
(Mavromichalis et al., 2000; Sergeant et al., 2010). In order for ZnO to reach the lower 
gut, though, a portion is necessarily absorbed in the upper gut and this ‘absorptive loss’, 
due to the passage through the stomach and the upper gut, would justify the use of high 
doses of ZnO. Microencapsulation was previously demonstrated to overcome the 
stomach barrier and to allow a release of active principles along the gut by preventing a 
complete absorption (Piva et al 2007; Grilli et al. 2010; Grilli et al., 2013). Aim of this 
study was to investigate whether lipid microencapsulation could reduce ZnO in-feed 
inclusion by comparing the effects of feeding low doses of microencapsulated ZnO 
versus pharmacological dose of free ZnO on piglets growth performance, ileal 
architecture, and glucose transporter SGLT-1. 
 
MATERIALS AND METHODS 
The study was conducted at the facilities of the Research Centre for Animal Production 
and Environment (CERZOO), which is Good Laboratory Practices-certified and 
operates according to the procedure of animal protection and welfare (Directive No 
86/609/EEC). 
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Animals and Diets 
One hundred and forty-four Landrace × Large White male and female piglets, weaned 
at 28 days of age and 7.2 kg of BW, were divided in 36 pens and randomly assigned to 
one of the following experimental groups: the basal diet (control), providing Zn at 50 
mg/kg; the basal diet added with free ZnO at 3,000 mg/kg (fZnO, providing Zn at 2,850 
mg/kg); the basal diet supplemented with microencapsulated ZnO at 300 mg/kg or 800 
mg/kg, providing Zn at 140 mg/kg or at 380 mg/kg (mZnO-300 and mZnO-800, 
respectively).  
The basal feed was formulated in order to meet or exceed the nutritional requirements 
of pigs according to NRC (1998) but without supplemental Zn. Supplemental Zn 
sources were added to the basal diet in order to provide the amount of Zn necessary for 
each experimental diet. Feed and water were provided ad libitum and piglets were fed 
the experimental diets for 42 days. At the end of the first 2 weeks the diet was switched 
to meet the nutritional requirements of the pigs in the second phase (Table 1). The 
health status of animals was monitored throughout the study and any culling or 
mortality was registered. 
Piglets were individually weighed at the beginning of the study (d0), after 7 days (d7), 
at the end of the first growing phase (d14), and at the end of the study (d42). Feed 
intake was measured per pen during the same time intervals. Average daily gain 
(ADG), average daily feed intake (ADFI) and gain to feed ratio (G:F) were calculated 
for each phase (0 to7 d, 7 to 14 d, 14 to 42 d) and for the overall period (0 to 42 d). 
At d14 and d42 of the study, 6 pigs per treatment (one per 6 randomly selected pen per 
treatment) were euthanized to collect intestinal samples: the ileum was longitudinally 
cut 10 cm from the ileal-cecal valve to expose mucosa, washed with PBS to remove 
mucus and digesta, then scraped gently with a glass slide, vacuum-packed  and 
immediately stored in liquid nitrogen until gene expression analysis. Histological 
samples were instead collected and fixed in formalin until staining. 
At the time of sacrifice blood samples were also collected to perform plasma Zn 
analysis. Blood was collected by jugular venipuncture using 10 cc heparinized (lithium 
heparin) disposable syringes (Becton Dickinson, Franklin Lakes, NJ) and centrifuged at 
room temperature for 10 min at 3,000 × g; plasma was transferred with Pasteur pipette 
in a plastic test tube and frozen at –80°C until analysis. 
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Table 1. Composition of basal diets (as-fed basis) 
 1st phase 
(0 to14 d) 
2nd phase 
(14 to 42 d) 
Ingredients, %   
Corn meal 40.00 40.00 
Soybean meal, 44% 19.81 20.00 
Barley meal 20.34 22.63 
Sweet milk whey 8.00 4.00 
Soft wheat bran 5.00 8.00 
Potato proteins 2.50 1.00 
Soybean oil 1.37 1.50 
Calcium carbonate 1.00 1.12 
Vitamin and mineral 
premix
1
 
1.00 1.00 
Calcium phosphate 0.60 0.54 
L-Lys HCl 0.53 0.44 
NaCl 0.35 0.40 
L-Tre 0.21 0.17 
DL-Met 0.22 0.15 
L-Trp 0.07 0.05 
   
Nutrients, % DM   
DM 89.92 89.82 
CP 20.12 19.48 
EE
2
 4.03 4.73 
CF
3
 4.28 4,88 
Ash 5.74 5.78 
Starch 40.08 44.59 
Ca 0.79 0.80 
Total P 0.58 0.59 
Zn mg/kg 50 45 
DE
4
, kcal/kg 3,839 3,836 
NE
5
, kcal/kg 2,862 2,868 
1
: Providing per kilogram of premix: vitamin A, 1,500,000 UI; vitamin D3, 170,000 UI; vitamin E, 4,000 
mg; vitamin B1, 200 mg; vitamin B2, 500 mg; vitamin B6, 250 mg; vitamin B12, 4 mg; vitamin H, 15 mg; 
vitamin K, 250 mg; vitamin PP, 3,000 mg; D-pantotenic acid, 1,500 mg; choline cloride, 38,500 mg; 
folic acid, 100 mg; Mn, 6,100 mg from manganese oxide; Fe, 15,000 mg from iron sulfate; Cu, 7,600 mg 
from copper sulfate; Co, 50 mg; I, 150 mg from potassium iodide; Se, 30 mg from sodium selenite. 
2
: EE = ether extract 
3
: CF = crude fiber 
4
: According to the equation proposed by Whittemore 1987 
5
: According to the equation proposed by Noblet 1994 
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Chemical Analysis 
The DM, CP, ether extract, crude fiber, ash, and starch contents of the feed were 
determined according to the AOAC (2000) methods. Zn in feed and plasma were 
analyzed by Inductively Coupled Plasma Atomic Emission Spectrometry (EPA method 
6010C, 2000) by using the Optima 2100 DV ICP/OES instrument (PerkinElmer, Inc. 
Shelton, CT). 
 
Ileal Histometry and Immunohistochemistry 
Haematoxylin and Eosin staining was carried out to assess the ileum micro-anatomical 
structure and perform histometry. For histometry, the following parameters were 
evaluated per section: villous height (V; 10 villi measured per section), crypt depth (C; 
10 crypts measured per section), the villous height to crypt depth ratio (V:C). On other 
sections, the ileum mucin profile, and the respective histometry (number of mucous 
cells) were determined by staining sections with the Alcian blue 8GX pH 2.5-periodic 
acid Schiff (AB-PAS) sequence, which reveals neutral (PAS-reactive, purple stained) 
and acid (AB-reactive, azure stained) glycoconjugates. The number of mucous cells 
was determined in 5 villi and 5 crypts of each section. 
Other ileal sections were processed by immunohistochemistry or immunofluorescence 
to reveal proliferating epithelial cells (PCNA; 1:1000; clone PC10, Sigma, Italy) and 
entero-endocrine serotonin secreting cells (1:100; AB938; Millipore Merck S.p.A., 
Milan, Italy). Proliferating cells were counted in 6 crypts of each section. The number 
of enterochromaffin serotonin-secreting cells (EC) was evaluated in 8 randomly 
selected visual fields of the mucosa (each field representing a tissue section area of 
77,323.25 μm2 at 400X) for each section, and the density was expressed as number of 
cells/mm
2
 of mucosa. 
For histology, histochemistry and immunohistochemistry, all the observations were 
made by a single investigator, blind to the pig groups, using an Olympus BX51 
microscope (Olympus Italia Srl, Milan, Italy) equipped with a digital camera and DP 
software for computer-assisted image acquirement and management. 
Immunofluorescence reactions were observed using a Confocal Laser Scanning 
Microscope (FluoView FV300, Olympus Italia Srl, Milan, Italy). 
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Sodium-dependent Glucose Transporter (SGLT-1) Gene Expression 
Ileal scraping samples were disrupted by grinding in liquid nitrogen with mortar and 
pestle, then homogenized using TissueLyser (Qiagen, Hilden, Germany). Total RNA 
was isolated using RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s instructions. Genomic DNA contamination was removed by treatment 
with deoxyribonuclease (RNase-Free DNase Set, Qiagen, Hilden, Germany). RNA 
yield and quality were determined spectrophotometrically using A260 and A280 nm 
measurements. All samples showed A260:A280 ratio of 1.8-2.0. A total of 1 µg of RNA 
was reverse-transcribed with iScript cDNA Synthesis Kit (Bio-Rad Laboratories Inc., 
Hercules, CA) according to the manufacturer’s instructions. Resulting cDNA was 
quantified with Quant-iT Oligreen ssDNA Assay (Life Technologies Italia, Monza, 
Italy) to normalize the quantity of cDNA template used for amplification by real-time 
PCR. Real-time PCR was performed using iCycler Thermal Cycler system and 
SybrGreen Supermix (Bio-Rad Laboratories Inc., Hercules, CA). Thermocycling 
protocol included initial denaturation for 1 min and 30 s at 95°C, 40 cycles of 
denaturation at 95°C for 15 s followed by 30 s of annealing and extension at 60°C. 
After amplification, all samples were subjected to a melt curve analysis, with a slow 
heating from 55 to 95°C with a rate of 0.5°C/s to validate absence of non-specific 
products. 
Gene expression was normalized using two housekeeping genes coding for portions of 
porcine ribosomal subunit 60S, such as ribosomal protein L35 (RPL35) and ribosomal 
protein L4 (RPL4). Average threshold cycle (CT) was determined for each gene of 
interest (GOI), and geometric average was calculated for housekeeping genes (HKs), 
assuming CT as number of cycles needed to reach a fixed arbitrary threshold. Delta CT 
was calculated as CT GOI – CT HKs, then a modification of the 2
–ΔΔC
T (Livak and 
Schmittgen, 2001) method was used to analyze the relative expression (fold changes), 
calculated relative to the control group.  
The gene specific primers for SGLT-1, RPL35, and RPL4 were as follows: forward 5’-
TGCTGTTTCCAGATGATGTGGGCT-3’, reverse 5’-
TGCTGCTGCTGTTAAAGATGGACG-3’ for SGLT-1 (198 bp); forward 5’-
AACCAGACCCAGAAAGAGAAC-3’, reverse 5’-TTCCGCTGCTGCTTCTTG-3’ for 
RPL35 (146 bp; Alexander et al., 2012); forward 5’-CAAGAGTAACTACAACCTTC-
3’, reverse 5’-GAACTCTACGATGAATCTTC-3’ for RPL4 (122 bp; Alexander et al., 
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2012). Primers were obtained from Life Technologies (Life Technologies Italia, 
Monza, Italy). 
 
Statistical Analysis 
Animals were blocked in a completely randomized design and data were analyzed 
using one-way ANOVA with GLM procedure of SAS followed by Tukey post hoc test 
to detect differences among treatments (SAS Institute Inc., release 9.2, Cary, NC). The 
pen was the experimental unit for growth performance, whereas the pig was the 
experimental unit for histometry and immunohistochemical and SGLT-1 analysis. 
Differences were considered significant at P < 0.05 and trends were defined at 0.05 < P 
≤ 0.1. 
 
RESULTS 
Growth Performance and Plasmatic Zn 
Animals maintained a good health status throughout the experiment and mortality was 
low and not affected by the treatments (overall 1.4%). Diarrhea scouring evaluated on a 
semi-objective scale was not significantly different among the groups. Growth 
performance is showed in Table 2. During the first week there were no differences 
among treatments, but starting at d14, at the end of the first feeding phase, animals 
receiving ZnO had better performance compared to control. In particular, in the second 
week of growth (7 to 14 d) the fZnO group had greater ADG and lower ADFI than the 
control group (+32% and -13%, respectively; P = 0.002 and P = 0.004, respectively) , 
which resulted in a better body weight (+7%) and G:F (+54%), respectively (P = 0.02 
and P < 0.001, respectively ). 
Likewise, during the same week, the mZnO-800 group had an increased ADG than the 
control group (+18%) and a better G:F (+25%), whereas the group mZnO-300 had only 
a better G:F compared to the control group.  
In the second feeding phase (14 to 42 d), though there were no significant differences 
among treatments, the ADG of all of the groups receiving ZnO, regardless of the source 
and dose, was greater than the control group (+25% on average; P = 0.05). Also the 
G:F tended to be better in treated animals compared to the control (+26% on average; P 
= 0.06). 
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Table 2. Growth performance 
 Treatment
1
    
Item control fZnO mZnO-300 mZnO-800  SEM P 
BW, kg        
d0 7.04 7.15 7.22 6.98  0.10 0.29 
d7 8.35 8.58 8.58 8.40  0.13 0.45 
d14 9.89
a
 10.61
b
 10.30
ab
 10.21
ab
  0.15 0.02 
d42 20.49
a
 22.65
b
 22.11
b
 22.22
b
  0.46 0.01 
        
0 to7 d        
ADG, g/d 187.7 204.0 193.7 203.2  9.85 0.60 
ADFI, g/d 267.3 249.7 243.0 256.7  14.45 0.67 
G:F 0.73 0.85 0.80 0.81  0.06 0.54 
        
7 to 14d        
ADG, g/d 220.1
a
 290.5
c
 230.6
ab
 258.7
bc
  12.83 0.002 
ADFI, g/d 456.2
b
 397.8
a
 396.4 
a
 435.5
b
  12.69 0.004 
G:F 0.48
a
 0.74
b
 0.58
c
 0.60
c
  0.03 < 0.0001 
        
14 to 42d        
ADG, g/d 282.6 347.2 357.6 351.4  20.67 0.05 
ADFI, g/d 743.5 719.4 732.4 749.8  34.22 0.93 
G:F 0.39 0.50 0.50 0.47  0.04 0.11 
        
Overall        
ADG 230.1
a
 280.6
b
 247.8
ab
 271.1
b
  11.40 0.02 
ADFI 489.0 455.6 457.3 480.6  16.38 0.39 
G:F 0.48
a
 0.64
b
 0.60
b
 0.59
b
  0.03 0.002 
a-c
 Within a row, means without a common superscript differ (P < 0.05). 
1
 Treatments: control = basal diet providing Zn at 50 mg/kg; fZnO = basal diet + free ZnO providing Zn 
at 2,850 mg/kg; mZnO-300 = basal diet + microencapsulated ZnO providing Zn at 140 mg/kg; mZnO-
800 = basal diet + microencapsulated ZnO providing Zn at 380 mg/kg. 
 
The overall performance (0 to 42 d) was in favor of the groups receiving ZnO either 
free or microencapsulated. In fact, between 0 to 42 d fZnO and mZnO-800 pigs had 
20% higher ADG than the control (P = 0.02), whereas mZnO-300 had intermediate 
ADG. Nonetheless, at d42, all of the groups weighed on average 9% more than control 
group and G:F was on average 10 points higher (P = 0.01 and P = 0.002, respectively).  
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Zn source significantly affected Zn plasma levels at both stages, as ZnO at 3000 mg/kg 
had the greatest values (P < 0.01). In particular, plasma Zn concentration at d14 was 
15, 23, 14.5, and 18 µmol/L for control, fZnO, mZnO-300 and mZnO-800 groups, , 
respectively. At d42 plasma Zn concentration was 10, 30, 10 and 12 µmol/L for control, 
fZnO, mZnO-300 and mZnO-800 groups, respectively. 
 
Ileal Histometry and Immunohistochemistry 
The histometrical results are summarized in Table 3. At d14 the villi were the longest in 
the ileum of mZnO-800 treated animals whereas they were the lowest in control piglets 
(P < 0.0001). The crypt depth did not reveal significant differences among the groups, 
but the V:C ratio was higher in fZnO, mZnO-300, and mZnO-800 than in control 
piglets (P = 0.0002). Zinc oxide treatments did not influence the goblet cells numbers. 
The percentage of proliferating cells, which were counted in the ileal crypts, was lower 
in piglets of control group than in fZnO, mZnO-300, and mZnO-800 groups (P = 
0.0001). The number of mucosal endocrine serotonin-secreting cells was not affected 
by dietary supplementations. 
At d42 the villi length and V:C ratio were higher in the ileum of fZnO animals in 
comparison with the other groups (P < 0.0001). The crypt depth was not different 
among the groups. The percentage of proliferating cells, which were counted in ileal 
crypts, was greater in piglets of mZnO-800 group than in control, mZnO-300, and fZnO 
animals (P < 0.0001). Endocrine serotonin-secreting cells tended to be more numerous 
in ileum of mZnO-300 and mZnO-800 animals than in control and fZnO piglets (P = 
0.09), whereas goblet cells number was not affected. 
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Table 3. Ileal histometry and immunohistochemistry 
 Treatment
1
    
Item control fZnO mZnO-300 mZnO-800  SEM P 
d14        
Villous height, μm 309.36a 316.98ab 329.81bc 342.74c  5.55 < 0.0001 
Crypt depth, μm 331.69 322.74 321.57 335.63  5.36 0.12 
V:C
2
 0.94
a
 0.99
b
 1.04
b
 1.03
b
  0.02 0.0002 
Goblet cells / crypt 33.27 29.95 34.23 33.13  1.53 0.22 
Goblet cells / villous 19.60 19.89 18.49 21.11  1.14 0.46 
PCNA
3
, % 86.02
a
 88.82
b
 90.93
b
 90.80
b
  0.85 0.0001 
EC
4
, % cells/mm
2
 52.87 45.66 50.65 50.38  2.59 0.25 
d42        
Villous height, μm 293.87a 327.01b 303.11a 294.13a  5.16 < 0.0001 
Crypt depth, μm 325.11 332.50 333.81 325.22  4.93 0.42 
V:C
2
 0.92
a
 0.99
b
 0.92
a
 0.91
a
  0.02 0.02 
Goblet cells / crypt 23.08 26.09 25.43 24.03  0.94 0.12 
PCNA
3
, % 90.84
a
 89.83
a
 89.93
a
 93.78
b
  0.56 < 0.0001 
EC
4
, % cells/mm
2
 42.30 43.38 47.96 49.94  2.47 0.09 
a-c
 Within a row, means without a common superscript differ (P < 0.05). 
1
 Treatments: control = basal diet providing Zn at 50 mg/kg; fZnO = basal diet + free ZnO providing Zn 
at 2,850 mg/kg; mZnO-300 = basal diet + microencapsulated ZnO providing Zn at 140 mg/kg; mZnO-
800 = basal diet + microencapsulated ZnO providing Zn at 380 mg/kg. 
2
 V:C = villi height : crypts depth  
3 
PCNA = proliferating cell nuclear antigen positive cells 
4
 EC = enterochromaffin cells 
 
SGLT-1 
Figure 1 shows SGLT-1 gene expression in ileal mucosa at d14 and d42. At d14, 
SGLT-1 mRNA relative expression was the lowest in mZnO-800 pigs compared to 
mZnO-300, whereas the control and fZnO groups had intermediate values (P = 0.02). 
At d42, both groups receiving microencapsulated ZnO tended to have a reduced mRNA 
abundance than the control and fZnO groups (P = 0.06). 
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Fig. 1. Gene expression of SGLT-1 in ileal mucosa at d14 and d42. 
Data are expressed as means (n = 6) and SEM represented by vertical bars. 
a,b
 Within the same time point mean values with unlike letters were significantly different (P<0.05). 
Control = basal diet providing Zn at 50 mg/kg; fZnO = basal diet + free ZnO providing Zn at 2850 
mg/kg; mZnO-300 = basal diet + microencapsulated ZnO providing Zn at 140 mg/kg; mZnO-800 = basal 
diet + microencapsulated ZnO providing Zn at 380 mg/kg. 
A modification of the 2
–ΔΔC
T method was used to analyze the relative expression (fold changes), 
calculated relative to the control group (control), (Livak & Schmittgen, 2001). 
 
 
DISCUSSION 
Dietary ZnO at 2,500‒3,000 mg/kg of feed is extensively used in worldwide pig 
production since in the late 80’s Poulsen described it as an anti-diarrhea agent and a 
growth promoter (Poulsen, 1989). Many researches have in fact consistently reported 
that pigs benefit from supplemental ZnO at pharma levels in the first weeks post 
weaning, but increasing concerns on environmental pollution drove European 
legislators toward a more attentive policy on the excretion of heavy metals in manure 
(Carlson et al., 1999). With this perspective, the aim of this study was to investigate 
whether lipid microencapsulation could help reducing ZnO dietary inclusion by 
comparing the effects of low doses of microencapsulated ZnO to a pharmacological 
dose of free ZnO on piglets growth performance and intestinal architecture. 
Numerous ZnO mechanisms of action have been reported over the years and it has been 
recently demonstrated that 2,000‒3,000 mg/kg of Zn provided as ZnO increase the 
insulin-like growth factor-I and insulin-like growth factor-I receptor expression in the 
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intestinal mucosa and stimulate feed intake via ghrelin secretion from the stomach, 
thereby enhancing growth performance (Li et al., 2006; Yin et al., 2009). In our study, 
we measured a significant improvement of the average daily gain in the second week 
post-weaning due to the supplementation of ZnO, which was not supported by an 
increased feed intake, as reported also in other researches (Case et al., 2002; Li et al., 
2006; Ou et al., 2007). The increased daily growth was dependent on the amount of 
ZnO fed rather than on the source and resulted in a higher body weight in pigs fed with 
ZnO at 3,000 mg/kg than in control animals and in a better feed conversion for all of 
the groups treated with ZnO compared to control after 14 days from weaning. During 
the second phase of growth all of the groups receiving ZnO tended to have better gain 
and feed efficiency compared to control, but again no impact on feed intake was 
measured due to ZnO. Beyond an increased feed intake, one of the most accounted 
hypothesis about ZnO mechanism of action is that Zn is anti-oxidant and anti-
inflammatory, thereby implicating a host effect in the response to Zn. Sargeant and 
colleagues recently demonstrated a modulation of the innate immune response of IPEC 
cells and an inhibition of nuclear factor-kappa B following E. coli infection mediated 
by Zn as ZnO (Sargeant et al., 2011). Also Roselli et al. (2003) demonstrated a lower 
immune response of Caco-2 cells infected with ETEC K88 in presence of high levels of 
ZnO. This decreased intestinal inflammatory response during challenging insults would 
eventually improve the intestinal integrity and barrier function, and, as a consequence, 
piglets would convert feed in a more efficient way and result in a better growth (Faa et 
al., 2008; Prasad et al., 2008; Zhang & Guo, 2009). The hypothesis that a better growth 
performance is supported by a less inflamed and more absorptive intestine is here 
substantiated by the results on ileal morphometry. The trophic effect of ZnO on 
intestinal villi was also reported by other researchers, though generally at jejunal level 
(Li et al., 2006; Mavromichalis et al., 2000), and in our study 14 days after weaning 
piglets receiving ZnO, and in particular in the microencapsulated form, had an higher 
villi height and villi to crypts ratio compared to control. These parameters were also 
correlated to the number of cells positive to PCNA staining, indicating that the small 
intestine of ZnO treated animals was in a more trophic status than control animals. At 
weaning the intestinal mucosa undergoes several structural changes such as the 
reduction of villi height and an increase in crypts depth (Pluske et al., 1997); the 
shortening of villi and the consequent reduction of the intestinal absorptive surface help 
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to explain the increased susceptibility of the pig to infections and diarrhea. Because 
shorter villi and deeper crypts have fewer absorptive and more secretory cells, 
absorption might be poorer when villi are shorter therefore leading to an higher 
abundance of indigested nutrients in the distal part of the small intestine. SGLT-1 is a 
Na-dependent co-transporter of glucose  whose expression can be reduced when 
glucose availability is reduced (Dyer et al., 1997; Woyengo et al., 2011) and in our data 
we did find the lowest relative abundance of SGLT-1 mRNA in pigs receiving 
microencapsulated ZnO at the highest dose. The lowest mRNA synthesis of SGLT-1 
matched the highest villi length for the Zn800 group, thereby suggesting a down-
regulation of SGLT-1 gene due to a lower availability of luminal glucose and to a lower 
amount of undigested nutrients at ileal level. This hypothesis is further confirmed by a 
work of Woodword and colleagues where ileal SGLT-1 expression was decreased by 
rapidly digestible starch in comparison with slowly digestible starch. They postulated 
that slowly digestible starch is digested more in the ileum than in the upper small 
intestine therefore increasing luminal glucose and SGLT-1 expression, whereas, by 
contrast, rapidly digestible starch would be digested more in the upper part of the GI 
tract (Woodword et al., 2012). A lower expression of SGLT-1 in pigs fed with 
microencapsulated ZnO was also still appreciable at the end of the study (d42). 
In the second phase, though performance did not significantly differ, there was a strong 
trend in an improved growth and feed efficiency in all of the animals receiving ZnO, 
regardless of the dose, which resulted in about 2 kg heavier animals compared to 
control ones. Conversely to the first phase, the longest villi and the highest V:C was 
this time observed in animals fed with 3,000 mg/kg of free ZnO, whereas pigs fed with 
microencapsulated ZnO did not differ from the control. Pigs fed with 
microencapsulated ZnO at the highest dose (800 mg/kg) tended to have a higher 
number of EC cells than the fZnO and control groups. These cells are main mediators 
of intestinal peristalsis and secretory activity in response to chemical and mechanical 
stimuli via release of serotonin and have been reported to be mainly expressed during 
the restoration of the epithelial lining, either by the natural process of repair or by the 
presence of inflammatory mediators during inflammation (Linden et al., 2003). In light 
of these findings it might be therefore derived that pigs fed with microencapsulated 
ZnO at 800 mg/kg were undergoing a remodeling of the ileal mucosa as suggested also 
by the higher number of cells undergoing synthesis and positive to PCNA staining.  
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Plasmatic Zn levels of pigs fed with microencapsulated ZnO did not increase compared 
to the control, whereas plasmatic Zn in pigs supplemented with 3,000 mg/kg of ZnO 
were significantly higher compared to both control and the other groups. This latter 
finding, in addition to the effects observed on the ileal mucosa, would suggest a 
different availability of Zn from microencapsulated ZnO compared to free ZnO. Zn 
availability is strongly dependent on the source and ZnO has been univocally 
demonstrated to be less available of ZnSO4 or other salts, despite the higher efficacy 
(Hahn & Baker, 1993; Wedekind et al., 1994; Shell & Kornegay, 1996). Hahn and 
Baker (1993) found that ZnO at pharmacological level was more effective than same 
level of ZnSO4 in improving piglets feed intake and growth in the post-weaning phase 
despite a lower plasma Zn, and they suggested an inverse relationship between 
plasmatic Zn and Zn efficacy. This would imply that a lower rate of absorption  is 
therefore necessary in order for Zn to reach the hindgut and exert its anti-inflammatory 
role in the ileum, where the major part of inflammatory response takes place. Hence, if 
Zn plasma concentration is a method to predict Zn efficacy, microencapsulation might 
have prevented the absorptive loss in the proximal jejunum while still allowing Zn to 
reach the ileum despite a 7-times lower dose compared to pharmacological ZnO.  
In conclusion, from this study we can derive two sets of information. First, ZnO 
improved the growth of pigs by increasing ADG during the second week post weaning 
in a dose-dependent way, and the growth effect was also sustained by an improved 
absorptive surface at ileal level, especially when ZnO was fed microencapsulated. 
Second, lipid microencapsulation allowed to reduce ZnO inclusion dose by at least 
seven times by preventing ZnO immediate absorption in the upper gut and conveying 
Zn to the ileum in sufficient amount to promote pigs growth and a more mature ileal 
mucosa.  
We here propose microencapsulated ZnO as an effective and environment-friendly tool 
to supplement pigs post weaning diets. 
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ABSTRACT 
Aim of this study was to evaluate growth performance, intestinal architecture and gene 
expression of inflammatory cytokines and tight junction proteins in weaning piglets fed 
with tributyrin, either free or microencapsulated, as dietary source of butyric acid. One 
hundred-eight weaned pigs (28 days) divided in 27 pens (n = 9), received either a basal 
diet (control, 0 mg/kg butyric acid) or the basal diet supplemented with tributyrin or its 
encapsulated form at 1,750 mg/kg (f-TB and m-TB, respectively), both providing 960 
mg/kg of butyric acid equivalents. After 21 days, 7 pigs per group were euthanized to 
collect intestinal samples (duodenum, jejunum, ileum, colon) for histo-morphology, 
cytokines, and tight junction markers gene expression analysis. Pigs BW and feed 
intake were recorded at 0 and 21 d, and ADG and FCR were calculated. Data were 
analyzed with 1-way ANOVA. No significant effects were observed on growth 
performance parameters. Compared to control, m-TB induced deeper crypts in the 
duodenum (P = 0.09), numerically longer villi in the jejunum and significantly reduced 
villi:crypts ratio in the ileum (P = 0.04); goblet cells tended to be reduced by f-TB in 
duodenal villi (2.4 fold, P = 0.09), by both f-TB and m-TB in ileal villi (1.8‒2.2 fold, 
respectively; P = 0.06), and by m-TB in colonic crypts (P = 0.08). Compared to control, 
f-TB showed higher TNF-α expression in duodenal and ileal mucosa (P = 0.06 and P = 
0.10), and significantly higher IFN-γ level in the jejunum (P = 0.04), whereas in the 
colon m-TB down regulated IFN-γ (2.2 fold, P = 0.06) and IL-1β level (1.7 fold). 
Jejunal claudin-1 mRNA was significantly reduced in both groups receiving tributyrin 
compared to control (1.5‒2.4 fold, for f-TB and m-TB; P = 0.05). Similarly, in the 
colon claudin-1 mRNA was numerically lower in m-TB (2.1 fold) than in control group 
and f-TB had intermediate value. Ileal occludin mRNA was significantly reduced in 
both groups receiving tributyrin compared to control (1.6‒2.2 fold, for f-TB and m-TB; 
P < 0.01). In the colon occludin mRNA was downregulated both in f-TB and m-TB 
compared to control (1.4 fold both; P < 0.05). The supplementation of tributyrin in the 
diet modulated the intestinal architecture by reducing the mucous-secreting goblet cells 
in a tract-specific way, free tributyrin affecting the upper intestine while the 
microencapsulated form acting in the lower gut. Moreover, the reduced expression of 
pro-inflammatory cytokines, observed particularly in the colon, and the regulation of 
tight junctions proteins further substantiate the local anti-inflammatory role of butyric 
acid, released via tributyrin, in the large intestine. 
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INTRODUCTION 
Weaning is the most critical period in the piglet’s life because of a complex series of 
stressors (social, nutritional, environmental) associated with physiological, anatomical 
and immunological changes in the gastro-intestinal tract that impair the intestinal 
functions – digestion, absorption and barrier function – thus leading to reduced growth 
efficiency and higher incidence of infections and intestinal disturbances, such as post-
weaning diarrhea (Pluske et al., 1997). 
Among the strategies to help in overcoming this post- weaning growth retard, organic 
acids have been widely used due to their growth promoting effects, mainly based on 
their acidifying and anti-microbial properties. Among these acids, butyric acid seems 
particularly interesting because of its multi-functional role in the intestine: first, butyric 
acid is the primary energy source for the epithelial cells in the colon and in the terminal 
ileum (Roediger, 1980; Chapman et al., 1995); in addition, multiple beneficial effects 
on the intestinal cell homeostasis can be ascribed to butyric acid, such as anti-
inflammatory, anti-oxidant, anti-apoptotic and proliferative, anti-carcinogenic, and 
protective action on the epithelial barrier integrity (by strengthening the tight 
junctions). In pigs, in-feed butyric acid, as sodium butyrate, has been shown to improve 
growth performance when fed in the first two weeks post-weaning (Piva et al., 2002a; 
Manzanilla et al., 2006) as well as in the fattening phase (Gálfi & Bokori, 1990). 
Tributyrin (TB) is a triglyceride containing three molecules of butyric acid esterified 
with glycerol. Since it is watersoluble, TB can be directly absorbed by the intestinal cell 
and, once inside, it is rapidly hydrolyzed into three molecules of butyric acid by 
specific cellular lipases (Leonel et al., 2013; Gaschott et al., 2001). Moreover, due to its 
not volatile and odorless nature, TB can be provided orally as a dietary source of 
butyric acid. Previous studies showed that tributyrin improved growth performance, 
intestinal morphology and enzyme activity in weaning piglets (Hou et al., 2006). In 
addition, Piva et al. reported that the synergistic effect of tributyrin and lactitol, as 
precursor and fermentable source of butyric acid, could improve the trophic status of 
the intestinal mucosa and control intestinal histamine in nursery piglets (Piva et al., 
2002b). However, despite the above mentioned protective and anti-inflammatory 
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properties of butyric acid discovered in vitro in cellular models, no in vivo studies have 
been conducted focusing on the impact of tributyrin on the weaning-associated 
inflammation and intestinal barrier dysfunction occurring in the gut of weaning piglets. 
Therefore, the aim of the study was to investigate the effects of supplementation of 
tributyrin, either free or encapsulated in a lipid matrix, as dietary source of butyric acid, 
on growth performance, intestinal architecture and expression of inflammatory 
cytokines and tight junction proteins in weaning piglets. 
 
MATERIALS AND METHODS 
The study was conducted at the research facilities of the Research Centre for Animal 
Production and Environment (CERZOO), which is a Good Laboratory Practices-
certified facility and operates according to the procedure of animal protection and 
welfare (Directive 86/609/EEC). 
Experimental Design and Sample Collection 
One hundred and eight pigs (Landrace × Large White, barrows and gilts, 6.67 (SE 0.07) 
kg of BW) weaned at 28 days of age were divided in 27 pens and randomly assigned to 
one of the following experimental groups (n = 9): the basal diet (control, providing 
butyric acid at 0 mg/kg); the basal diet added with 1,750 mg/kg of free tributyrin (f-
TB); the basal diet supplemented with microencapsulated tributyrin (m-TB) at 3,800 
mg/kg. Both f-TB and m-TB diets provided 960 mg/kg of butyric acid equivalents. 
The basal diet was formulated to meet or exceed requirements for weaned piglets 
recommended by the National Research Council (2012). Chemical analysis of the diet 
was performed and DM, CP, ether extract, crude fiber, ash, and starch contents of the 
feed were determined according to the AOAC (2000) methods. The composition of 
basal diet is reported in Table 1. 
The health status of animals was monitored throughout the study. Piglets were 
individually weighted at the beginning of the study (d0) and at the end of the study 
(d21). Feed was provided ad libitum and ADG, ADFI and FCR were calculated 
between 0 and 21 d. After 21 days 7 pigs per treatment were euthanized and intestinal 
samples were collected (duodenum, jejunum, ileum and colon). Intestinal samples were 
cut longitudinally to expose the mucosa and washed with PBS to remove mucus and 
digesta. Then the mucosa was scraped gently with a glass slide, vacuum-packed, 
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immediately frozen in liquid N2 and stored at −80°C until gene expression analysis was 
conducted. Histological samples were instead collected and fixed in formalin until 
staining. 
 
Table 1. Composition of basal diet (as-fed basis) 
 Nursery diet 
(0 to 21 d) 
Ingredients, %  
Corn meal 50.00 
Soybean meal, 48% 20.53 
Barley meal 13.84 
Milk serum 8.00 
Potato proteins 2.50 
Soybean oil 1.72 
Calcium carbonate 1.08 
Vitamin and mineral premix
1
 0.50 
Dicalcium phosphate 0.50 
L-Lys HCl 0.51 
DL-Met 0.21 
L-Thr 0.19 
L-Trp 0.08 
NaCl 0.34 
  
Nutrients, % DM  
DM 89.12 
CP 18.87 
EE
2
 4.19 
CF
3
 3.64 
Ash 4.64 
Starch 38.50 
DE
4
, kcal/kg 3,427 
NE
5
, kcal/kg 2,545 
1
: Providing per kilogram of premix: vitamin A, 3,000,000 UI; vitamin D3, 400,000 UI; vitamin E, 
12,000 mg; vitamin B1, 500 mg; vitamin B2, 1,200 mg; vitamin B6, 1,000 mg; vitamin B12, 6 mg; vitamin 
C, 15,000 mg; vitamin K, 500 mg; vitamin PP, 5,000 mg; D-pantotenic acid, 4,000 mg; choline cloride, 
69,200 mg; folic acid, 300 mg; biotin, 40 mg; Mn, 8,000 mg; Fe, 40,000 mg; Cu, 20,000 mg; Co, 80 mg; 
I, 300 mg; Zn, 24,000 mg; Se, 20 mg; sepiolite as anti-caking agent 50,000 mg; calcium carbonate, 
38.61%; wheat midding 15%). 
2
: EE = ether extract 
3
: CF = crude fiber 
4
: According to the equation proposed by Whittemore 1987 
5
: According to the equation proposed by Noblet 1994 
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Intestinal Histo-morphometry 
Small and large intestinal samples (duodenum, jejunum, ileum and colon) were 
formalin-fixed and paraffin-embedded and routinely stained (Hematoxilin-eosin). 
Slides were coded, and morphometric measures and goblet cells counting were carried 
out blindly by three skilled operators. All images were acquired with an optical 
microscope Leica DMLB, coupled to a Leica DFC camera (Leica Microsystems 
GmbH, Wetzlar, Germany). Acquired image were 2088×1550 pixel, Jpeg, The digital 
image analysis was conducted with ImageJ 1.46 
(http://rsbweb.nih.gov/ij/download.html). 
Hematoxilin-eosin stained slides were used for measurements of villous height/crypt 
depth by means of histo-morphometry of intestinal segments. Light microscope 
photographs were used to measure 10 of the tallest, best oriented villi from villous tip 
to crypt mouth, and 10 crypts from crypt mouth to base, adjacent to submucosa (Obj. 
10X). The villi height to crypt depth ratio (V:C ratio) was calculated (Brown et al., 
2006; Di Giancamillo et al., 2008; King et al., 2008). 
Other Hematoxilin-eosin stained slides were used for goblet cells counting. In crypts, 
goblet cells were counted in 5 best oriented crypts / intestinal tract, from crypt mouth to 
base (adjacent to submucosa). Number of goblet cells are expressed as mean number of 
goblet cells / 100 μm of crypts epithelium (mean data of crypt length) in order to supply 
the number of goblet cells / unit length of epithelium (linear density), that is more 
comparable with bibliographic data (Obj. 40X), (King et al., 2008). The equation to 
determine the number of goblet cells / 100 μm was: goblet cells / 100 μm = number of 
goblet cells × 100 / (crypt depth × 2), (King et al., 2008). In villi, goblet cells were 
counted in 5 best oriented villi/intestinal tract, from villous tip to base (adjacent to 
crypts mouth). Number of goblet cells are expressed as mean number of goblet cells / 
100 μm of villi epithelium (mean data of villous height) in order to supply the number 
of goblet cells / unit length of epithelium (linear density), that the is more comparable 
with bibliographic data (Obj. 40X), (King et al., 2008). The equation to determine the 
number of goblet cells / 100 μm was: Goblet cells / 100 μm = number of goblet cells × 
100 / (villi height × 2), (King et al., 2008). 
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Inflammatory Cytokines and Tight Junctions (TJ) Components Gene Expression 
Profiling 
Mucosa scrapings of duodenum, jejunum, ileum and colon were disrupted by grinding 
in liquid N2 with mortar and pestle, then homogenized using TissueLyser (Qiagen). 
Total RNA was isolated from ileal mucosa scraping using RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions. Genomic DNA contamination was 
removed by treatment with deoxyribonuclease (RNase-Free DNase Set, Qiagen). RNA 
yield and quality were determined spectrophotometrically using A260 and A280 nm 
measurements. All samples showed A260:A280 ratio of 1.8‒2.0. A total of 1 µg of RNA 
was reverse-transcribed with iScript cDNA Synthesis Kit (Bio-Rad Laboratories) 
according to the manufacturer’s instructions. Resulting complementary DNA (cDNA) 
was quantified with Quant-iT Oligreen ssDNA Assay (Life Technologies) in order to 
normalize the quantity of cDNA template used for amplification by real-time PCR. 
Real-time PCR was performed using iCycler Thermal Cycler system and SybrGreen 
Supermix (Bio-Rad Laboratories). Thermocycling protocol included initial denaturation 
for 1 min and 30 s at 95°C, 40 cycles of denaturation at 95°C for 15 s followed by 30 s 
of annealing and extension at 60°C. Following amplification, all samples were 
subjected to a melt curve analysis, with a slow heating from 55 to 95°C with a rate of 
0.5°C/s in order to validate absence of non-specific products. 
Gene expression was normalized using two housekeeping genes coding for portions of 
porcine ribosomal subunit 60S, such as ribosomal protein L35 (RPL35) and ribosomal 
protein L4 (RPL4). Average CT was determined for each gene of interest (GOI), and 
geometric average was calculated for housekeeping genes (HKs), assuming CT as 
number of cycles needed to reach a fixed arbitrary threshold. Delta CT was calculated 
as CT GOI−CT HKs, then a modification of the 2
–ΔΔC
T method was used to analyze the 
relative expression (fold changes), calculated relative to the control group (Livak & 
Schmittgen, 2001). 
The sequences, expected product length, accession number in the EMBL 
database/GenBank and references of porcine primers are shown in Table 2. Primer 
oligonucleotides for claudin-1, TNF-α, and IFN-γ were designed using PrimerQuest 
software (IDT, Integrated DNA Technologies). Primers were obtained from Life 
Technologies. 
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Table 2. Primers used for gene expression analysis by Real-Time PCR 
Gene Primer Sequence (F and R
1
; 5’ → 3’) Product 
lenght 
(bp) 
Product 
Tm
2
 
(°C) 
Accession 
number 
Reference 
Occludin F: ATCAACAAAGGCAACTCT 
R: GCAGCAGCCATGTACTCT 
157 83 NM_00116
3647.2 
Zhang and 
Guo, 2009 
Claudin-1 F: TCCAGTGCAAAGTCTTCGACTCCT 
R: ATGCCAACAGTGGCCACAAAGATG 
121 85.5 NM_00124
4539.1 
Present 
study 
TNF-α3 F: GCCCACGTTGTAGCCAATGTCAAA 
R: GTTGTCTTTCAGCTTCACGCCGTT 
99 87 NM_21402
2.1 
Present 
study 
IFN-γ4 F: GGCCATTCAAAGGAGCATGGATGT 
R: TGAGTTCACTGATGGCTTTGCGCT 
149 83.5 NM_21394
8.1 
Present 
study 
IL-1β F: ACCTGAACCTGCCAAGGAAGTGATG 
R: TCCCAGAGGGCTGAGGTCAAGG 
124 85 NM_00100
5149.1 
Present study 
RPL35
5
 F: AACCAGACCCAGAAAGAGAAC 
R: TTCCGCTGCTGCTTCTTG 
146 87.5 NM_21432
6.2 
Alexander 
et al., 2012 
RPL4
6
 F: CAAGAGTAACTACAACCTTC 
R: GAACTCTACGATGAATCTTC 
122 84 XM_00312
1741.3 
Alexander 
et al., 2012 
1
 F = forward primer, R = reverse primer 
2 
Tm = melting temperature 
3
 TNF-α = tumor necrosis factor-α 
4
 IFN-γ = interferon-γ 
5
 RPL35 = ribosomal protein L35 
6
 RPL4 = ribosomal protein L4 
 
 
Statistical Analysis 
Animals were grouped in a completely randomized design and data were analyzed with 
one-way ANOVA, followed by Tukey post hoc test (Graph Pad Prism 5 version 5.03; 
GraphPad Software, Inc., San Diego, CA). The pen was the experimental unit for 
growth performance, whereas the pig was the experimental unit for histomorphometry 
and for gene expression analysis. Differences were considered significant at P < 0.05 
and trends for 0.05 < P ≤ 0.1. 
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RESULTS 
Growth Performance 
Treatments with free or microencapsulated tributyrin did not affect growth performance 
parameters compared to control group (Table 3). 
 
Table 3. Growth performance 
 Treatment
1
    
Item control f-TB m-TB  SEM P 
BW, kg       
d0 6.66 6.69 6.66  0.07 0.92 
d21 11.92 11.34 11.75  0.35 0.50 
       
0 to 21 d       
ADG, g/d 262.9 232.1 254.5  17.6 0.45 
ADFI, g/d 438.8 416.4 441.8  21.9 0.68 
FCR 1.68 1.85 1.76  0.07 0.23 
1
 Treatments: control = basal diet (control, 0 mg/kg of butyric acid); f-TB = basal diet + free tributyrin at 
1,750 mg/kg (providing 960 mg/kg of butyric acid equivalents); m-TB = basal diet + microencapsulated 
tributyrin at 3,800 mg/kg (providing 960 mg/kg of butyric acid equivalents). 
BW, body weight; ADG, average daily gain; ADFI, average daily feed intake; FCR, feed conversion 
ratio. 
 
Intestinal Histo-morphometry 
Table 4 summarizes histometrical results and goblet cells counts in the intestinal tracts 
analyzed. In the duodenum, the villi length was not affected by the treatments, whereas 
the crypts tended to be deeper in pigs fed microencapsulated tributyrin compared to 
controls and free tributyrin treated (P = 0.09). However, no differences in V:C ratio 
were observed. In the jejunum, the villi were numerically longer in m-TB and 
numerically shorter in f-TB compared to control group, but no effects on crypt depth 
and V:C ratio were evident. In the ileum, villi and crypts were not affected by 
treatments, but V:C ratio was significantly lower in m-TB group compared to f-TB (P = 
0.04). The crypt depth in the colon was not influenced by the treatments. 
The goblet cells were counted in the villi and crypts of the intestinal tracts analyzed and 
are presented as numbers of goblet cells per 100 µm of villous or crypt. In the 
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duodenum, goblet cells numbers were not different in the crypts but in the villi tended 
to be reduced in the f-TB group compared both to control and m-TB (2.4 fold less, P = 
0.09). In the jejunum, no effects were observed in villi or crypts. In the ileum, goblet 
cells tended to be less numerous in the villi of both f-TB and m-TB groups compared to 
control (1.8 and 2.2 fold less, respectively; P = 0.06). In the crypts of the colon, goblet 
cells number tended to be reduced in m-TB group (P = 0.08). 
 
Table 4. Intestinal histo-morphometry 
 Treatment
1
    
Item control f-TB m-TB  SEM P 
Duodenum       
Villous height, μm 234.1 252.2 286.7  28.3 0.43 
Crypt depth, μm 356.7 376.8 427.8  20.8 0.09 
V:C
2
 0.66 0.69 0.62  0.08 0.83 
Goblet cells / 100µm villous 1.02 0.43 1.22  0.25 0.09 
Goblet cells / 100µm crypt 2.92 2.40 2.18  0.29 0.35 
Jejunum       
Villous height, μm 279.5 231.1 294.1  24.6 0.17 
Crypt depth, μm 253.9 257.3 276.1  25.9 0.83 
V:C
2
 1.12 0.93 0.99  0.09 0.36 
Goblet cells / 100µm villous 0.15 0.28 0.55  0.18 0.62 
Goblet cells / 100µm crypt 2.49 2.15 2.69  0.33 0.53 
Ileum       
Villous height, μm 213.6 240.2 226.7  19.6 0.64 
Crypt depth, μm 221.3 223.2 267  24.4 0.34 
V:C
2
 0.97
ab
 1.19
a
 0.89
b
  0.09 0.04 
Goblet cells / 100µm villous 2.25 1.24 1.03  0.34 0.06 
Goblet cells / 100µm crypt 4.77 5.39 4.24  0.56 0.37 
Colon       
Crypt depth, μm 349.5 347.1 370  27.2 0.82 
Goblet cells / 100µm crypt 4.42 4.09 3.08  0.28 0.08 
a-b
 Within a row, means without a common superscript differ (P < 0.05). 
1
 Treatments: control = basal diet (control, 0 mg/kg of butyric acid); f-TB = basal diet + free tributyrin at 
1,750 mg/kg (providing 960 mg/kg of butyric acid equivalents); m-TB = basal diet + microencapsulated 
tributyrin at 3,800 mg/kg (providing 960 mg/kg of butyric acid equivalents). 
2
 V:C = villi height to crypts depth ratio  
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Inflammatory Cytokines and TJ Markers Gene Expression Analysis 
Inflammatory cytokines mRNA levels in ileum, duodenum, jejunum, and colon are 
summarized in Fig. 1. In the duodenum, IFN-γ expression was not influenced by the 
treatments while TNF-α tended to be higher in f-TB group compared both to control 
and m-TB group (P = 0.06); IL-1β was not detected. In the jejunum, IFN-γ mRNA 
level was significantly higher in f-TB compared to both control and m-TB (P = 0.04); 
TNF-α was not different; IL-1β was not detected. In the ileum, no effects were 
observed on IFN-γ and IL-1β, while TNF-α expression tended to be higher in f-TB 
compared to m-TB group (P = 0.10). In the colon, IFN-γ level tended to be lower in m-
TB group compared to control (2.2 fold less, P = 0.06) and IL-1β level was numerically 
lower in f-TB group and m-TB (1.5 and 1.7 fold, respectively). TNF-α expression in the 
colon was not affected by treatments. 
 
 
Fig. 1. Gene expression of inflammatory cytokines in intestinal mucosa. 
Data are expressed as means (n = 7) and SEM represented by vertical bars. 
a,b
 Within a gene, mean values with unlike letters were significantly different (P < 0.05). 
A modification of the 2
–ΔΔC
T method was used to analyze the relative expression (fold changes), 
calculated relative to the control group (control), (Livak & Schmittgen, 2001). 
, control; , f-TB (free tributyrin at 1,750 mg/kg providing 960 mg/kg of butyric acid 
equivalents); , m-TB (microencapsulated tributyrin at 3,800 mg/kg providing 960 mg/kg of butyric 
acid equivalents). 
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Fig. 2 shows TJ components mRNA expression. Claudin-1 gene expression was not 
affected by treatments in the ileum. In the jejunum, claudin-1 mRNA level was 
significantly reduced in m-TB group compared to control (2.4 fold; P < 0.05), whereas 
f-TB group had intermediate value (1.5 fold less than control). Similarly, in the colon 
claudin-1 was numerically lower in m-TB group compared to control group (2.1 fold). 
No effects were evident on occludin gene expression in the jejunum. In the ileum, 
occludin mRNA level was significantly reduced in both groups receiving tributyrin 
compared to control (1.6 and 2.2 fold, for f-TB and m-TB, respectively; P < 0.01). In 
the colon, m-TB had significantly lower occludin level than control (1.4 fold, P < 0.05), 
whereas f-TB had intermediate value. 
 
 
 
Fig. 2. Relative gene expression of TJ components in intestinal mucosa. 
Data are expressed as means (n = 7) and SEM represented by vertical bars. 
a,b
 Within an intestinal tract, mean values with unlike letters were significantly different (P < 0.05). 
A modification of the 2
–ΔΔC
T method was used to analyze the relative expression (fold changes), 
calculated relative to the control group (control), (Livak & Schmittgen, 2001). 
, control; , f-TB (free tributyrin at 1,750 mg/kg providing 960 mg/kg of butyric acid 
equivalents); , m-TB (microencapsulated tributyrin at 3,800 mg/kg providing 960 mg/kg of butyric 
acid equivalents). 
 
DISCUSSION 
Butyric acid has been proposed as a nutritional tool to control weaning-associated 
intestinal dysfunction and subsequent growth failure in pig production, as a result of its 
well-known beneficial properties on the intestinal mucosa, mainly trophic effect on 
colonocyte and enterocyte, as well as anti-inflammatory, anti-oxidant, barrier-
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protective, anti-apoptotic and proliferative effect (Roediger, 1980; Chapman et al., 
1995; Leonel & Alvarez-Leite, 2012). Butyric acid is usually provided as salt, mainly 
sodium butyrate, due to its odor less strong than the acid, but alternative approaches 
have been documented such as butyric acid ester (tributyrin) or substrates to enhance 
microbial butyrogenic fermentations (lactitol, gluconic acid) (Piva et al., 2002b; Biagi 
et al., 2006). However, growth and intestinal health promoting effects have been shown 
to be dependent on several factors, above all, dose, supplementation duration, intestinal 
tract observed, and age of piglets (Lallès et al., 2009). 
The purpose of the present study was to assess the impact of the in-feed 
supplementation with tributyrin in weaning piglets and to compare free tributyrin and 
its microencapsulated form, as dietary source of butyric acid, with particular reference 
to small and large intestine architecture and inflammatory status, as key-elements for 
intestinal health and pig production. 
At weaning the intestinal mucosa undergoes several structural and functional changes 
(reduction of villi height, increase in crypts depth, impairment of enzymatic activity) 
that reduce the intestinal absorptive, digestive, and barrier function (Pluske et al., 
1997). In our study, dietary supplementation with tributyrin impacted intestinal 
morphology: compared to control animals, piglets receiving microencapsulated 
tributyrin tended to have deeper crypts in the duodenum, whereas piglets fed free 
tributyrin had higher villi to crypt ratio in the ileal mucosa. These results appear partly 
in contrast with previous works. Piva et al. reported no influence on jejunal villous 
length and drastic reduction in cecal crypt depth induced by tributyrin 2 weeks post-
weaning (Piva et al., 2002b). Again, Hou and colleagues in a four-weeks post-weaning 
trial showed decreased crypt depth both in the duodenum and in the ileum of tributyrin-
treated animals compared to controls (Hou et al., 2006). The discrepancy may rely on 
the different dose of tributyrin tested, 10,000 and 5,000 mg/kg (for Piva et al., and Hou 
et al., respectively), thus 3-6 times higher than our concentration. However, 
consistently to our findings, Mentschel and Claus, feeding pigs with resistant potato 
starch to increase microbial butyrate formation in the colon, found a decrease in the 
colonic crypt depth as a result of the anti-apoptotic action of butyrate, suggested by 
increased anti-apoptotic factor Blc-2 (Mentschel & Claus, 2003). 
Our most intriguing result was observed in the mucous-secreting goblet cells number 
where the dietary supplementation with tributyrin induced a reduction in the cells 
counts in a tract-specific way: free tributyrin affected the upper intestine while the 
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microencapsulated form impacted the lower gut. In this regard, microencapsulation 
seemed to allow an higher amount of tributyrin to be gradually released along the 
gastro-intestinal tract and reach the large intestine, whereas the free tributyrin appeared 
to be sooner available in the small intestine. This result is consistent with previous 
findings where slow release and targeted delivery of bio-active compounds was 
obtained with lipid microencapsulation (Piva et al., 2007; Grilli et al., 2010). The 
reduction in the mucous-secreting cells number may be explained by a beneficial and 
protective effect of tributyrin on the intestinal epithelium. Indeed, goblet cells number, 
induction and mucins secretion have been shown to be induced by a wide series of 
bioactive compounds, including hormones, neuropeptides, inflammatory cytokines, 
bacterial and parasitic products. Particularly, goblet cells hyperplasia and mucins 
hyper-secretion have been observed in many intestinal infections, caused by bacteria, 
parasites and viruses. For example, in Salmonella infections, mucins production and 
mucous release into the gut lumen is mediated by IFN-γ signaling (Kim & Khan, 2013). 
Thus, in our study, a protective action of tributyrin on the intestinal epithelium – maybe 
through an anti-inflammatory effect – may lead to reduced mucous-secreting goblet 
cells counts. 
Weaning represents a dramatic challenge to intestinal health and is known to be 
associated with up-regulation of pro-inflammatory cytokines IL-1β, TNF-α and IL-6 
(Pié et al., 2004). As a consequence, excessive inflammatory response can lead to tissue 
damage and intestinal dysfunction. Particularly, pro-inflammatory cytokines can affect 
intestinal barrier function and permeability through modulation of epithelial tight 
junctions as main regulators of the para-cellular route (Al-Sadi et al., 2009). To 
investigate the impact of tributyrin, either free and encapsulated, on small and large 
intestine inflammatory status and epithelial integrity, we analyzed a set of inflammatory 
cytokines and tight junctions components by gene expression. 
The main effect was observed in the colon where microencapsulated tributyrin allowed 
a trend for IFN-γ reduction and a numerical reduction of IL-1β, compared to control 
while free tributyrin had intermediate values. The reduction in pro-inflammatory 
cytokines levels induced by tributyrin, mostly when released from lipid encapsulation, 
may provide a protection for the colonic epithelium and affect its mucous-secreting 
cells set: less inflamed and damaged colon, less numerous goblet cells. This anti-
inflammatory action of tributyrin is consistent with the protective effect previously 
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described in experimentally induced colitis both in mice and pigs. In a murine model of 
dextran sodium sulfate (DSS)-induced colitis, tributyrin reduced the mucosal damage 
and the neutrophils infiltration induced by DSS in the colon, stimulating immune-
regulatory TReg cells and anti-inflammatory TGF-β and IL-10 cytokines (Leonel et al., 
2013). In addition, Hou et al. found that dietary tributyrin supplementation could 
alleviate intestinal injury in the acetic acid (ACA)-induced porcine model of colitis, by 
reducing lymphocytes counts both in plasma and in colonic mucosa (Hou et al., 2014). 
Moreover, an anti-inflammatory activity is accounted also for butyric acid that has been 
shown to reduce pro-inflammatory IFN-γ, TNF-α, IL-1β, IL-6, induce IL-10 and TGF-β 
expression, induce nitric oxide synthase (iNOS) and metalloproteinases and reduce 
lymphocytes proliferation and activation in several in vitro studies using cell models. 
The proposed mechanism of action involves the inhibition of the nuclear factor-kappa 
B (NF-KB), that controls the expression of genes coding for inflammatory cytokines, 
adhesion molecules, and inflammation-inducing enzymes (Leonel & Alvarez-Leite, 
2012). In addition, in piglets aged 40 days, Le Gall and colleagues (2009) observed a 
tendency by sodium butyrate to a reduced expression of IL-18 in the intestine (Le Gall 
et al., 2009). Despite the anti-inflammatory action of microencapsulated and ‒ to a 
smaller extent – free tributyrin in the colon, a stimulation of inflammatory cytokines 
was induced by free tributyrin in the upper gut. Particularly, in piglets fed free 
tributyrin, TNF-α mRNA tended to be hyper-expressed in the duodenum and in the 
ileum, while IFN-γ was significantly higher in the jejunum compared to both controls 
and microencapsulated tributyrin treated animals. We do not have a clear explanation 
for this surprising result as, to our knowledge, no immune-stimulatory or toxic effects 
have been described for butyric acid and tributyrin, in human or animal species, neither 
in pig trials testing butyric acid or tributyrin doses significantly higher than the dose we 
used in the current study. 
Butyric acid has also been shown to play an important role in maintaining the epithelial 
barrier function. Several in vitro studies, using both Caco-2 and IPEC-J2 cell models, 
revealed that butyric acid, as sodium butyrate, can improve epithelial integrity by 
strengthening inter-cellular tight junctions likely via activation of AMP-activated 
protein kinase (Ohata, 2005; Peng et al., 2009; Ma, 2012). A tighter epithelium can 
allow more efficient intestinal barrier function. In our experiment, dietary treatment 
with tributyrin modulated gene expression of tight junction components along the 
gastro-intestinal tract: particularly, in comparison to control, microencapsulated 
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tributyrin induced a significant reduction of occludin (in the ileum and in the colon) and 
claudin-1 (in the jejunum) mRNA levels, while free tributyrin showed intermediate 
values. Both occludin and claudin-1 are essential components of tight junctions, as they 
are trans-membrane proteins that anchor two epithelial cells and seal the inter-cellular 
space, thus regulating the para-cellular permeability (Turner, 2009). We hypothesize 
that the reduction in the gene expression of tight junctions components may be a result 
of a general improvement in the intestinal health induced by tributyrin: tributyrin may 
reduce the intestinal damage occurring in weaning and, therefore, less damaged 
epithelium could require less transcription of new tight junctions proteins. Particularly 
in the colon, this effect on tight junctions may be explained by the concomitant 
reduction in the expression of pro-inflammatory cytokines such as IFN-γ and IL-1β. In 
fact, IFN-γ has been described to exert a “leaky” action on the epithelium through the 
internalization of tight junctions proteins (mainly occludin) via macro-pinocytosis 
(Bruewer et al., 2005). In addition, IL-1β has been shown to increase intestinal 
epithelial permeability and to be markedly elevated in human intestinal inflammatory 
diseases such as IBD (Al-Sadi & Ma, 2007). Thus in the colon, tributyrin, reducing the 
pro-inflammatory milieu, may reduce the epithelial disruption and, as a consequence, 
reduce the necessity to express new tight junctions proteins. However, taking into 
account the unusual hyper-expression of inflammatory cytokines induced by free 
tributyrin in the upper gut, in addition to the proposed anti-inflammatory effect, we 
should also consider a cyto-protective action of tributyrin on the intestinal epithelial 
cells, likely by improving the trophic status. Tributyrin, as source of butyric acid, may 
in fact enhance cellular metabolism both directly, by increasing β-oxidation of butyric 
acid, and via an indirect pathway through the stimulation of trophic factors, including 
glucagon-like peptide-1 (GLP-1) and, even more, GLP-2. Moreover, in addition to the 
well known trophic effect, GLP-2 has been shown to exert a protective action on the 
epithelial integrity: in a Caco-2 cell model, GLP-2 enhanced the barrier formation 
(allowing higher TER) and attenuated TNF-α induced disruption of the TJ integrity 
(Moran et al., 2012). 
The improvement in the epithelial cellular health induced by tributyrin may be 
therefore reflected by reduced mucous-secreting goblet cells number and reduced 
expression of new tight junctions components, as healthier epithelium may not require 
additional defensive mechanisms. 
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Our growth performance data showed that, though modulating the intestinal 
architecture and health, tributyrin, either free or microencapsulated, did not result in 
improved pig growth. One possible explanation may rely in the doses tested: our 
concentrations (1,750 and 3,800 mg/kg for free and microencapsulated tributyrin, 
respectively) appear to be lower compared to those tested in previous studies, though 
results are conflicting. For example, tributyrin at 5,000 mg/kg has been shown to allow 
greater weight gain and better feed efficiency when fed for 4 weeks post-weaning (Hou 
et al., 2006). Conversely, Piva and colleagues (2002b) reported adverse effect on 
growth performance for tributyrin fed at 10,000 mg/kg for 2 weeks post-weaning, and 
attributed the negative effects to the high dose of tributyrin tested. For next studies it 
should be accurately evaluated the dose of tributyrin to be tested, however taking into 
account the great potential of the microencapsulated form that can be derived from the 
present study. Microencapsulation of tributyrin in a lipid matrix likely allowed an 
higher amount of tributyrin to be available in the colon, compared to free tributyrin, as 
reflected by the above-described tract-specific modulation of the intestinal architecture. 
Overall, tributyrin, both free and microencapsulated, has been shown to impact 
intestinal health by modulating intestinal architecture and expression of inflammatory 
cytokines and tight junctions components, thus being a promising tool to provide 
butyric acid to the intestine of weaning piglets. 
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ABSTRACT 
Dietary inclusion of organic acids and botanicals has been shown to improve pig 
performance, but the mechanism behind their efficacy has yet to be elucidated. The aim 
of this study was to assess the impact of dietary inclusion of a microencapsulated blend 
of organic acids (OA) and nature-identical compounds (NIC) on measures of intestinal 
health in early-weaned pigs. At the research facilities of the North Carolina State 
University, twenty pigs weaned at 18 d of age and placed into one of two pens (n = 10) 
received either a basal diet or the basal diet supplemented with OA+NIC mixture 
(5,000 mg/kg) for 14 d. Individual body weight were recorded initially and every 7d, 
and ADG was calculated. Blood samples were collected at d0, d7 and d14 for protein 
expression of inflammatory cytokines in serum. At the completion of the study, within 
each group the 6 pigs closest to their group mean ADG were selected for tissue 
collection. Ileal and jejunal samples were collected for Ussing chambers analysis of 
trans-epithelial electrical resistance (TER), intermittent short-circuit curret (ISC), and 
dextran flux. Scrapings of ileal mucosa were collected for analysis of cytokines (IL-6, 
IL-10, IL-12, TNF-α, IFN-γ, and TGF-β) at mRNA and protein level. Growth 
performance results showed that pigs fed the OA+NIC mixture had greater ADG during 
both the second week of the study and overall (P < 0.05). Pigs fed the OA+NIC mixture 
also had reduced jejunal dextran flux and ISC in the ileum (P < 0.12 and P < 0.07, 
respectively). The ileal gene expression of several cytokines (IL-12, TGF-β, IL-6) were 
downregulated in OA+NIC pigs and the corresponding proteins followed similar 
patterns. At d7 OA+NIC group showed higher serum levels of IL-12, IFN-γ and TNF-α 
compared to controls, while at d14 control group tended to have elevated IL-6. 
Overall, it appeared that dietary inclusion of the OA+NIC mixture improved intestinal 
health by allowing for tighter junctions in the jejunum (reduced dextran flux), and by 
possibly reducing the secretory activity of ileal mucosa (reduced ISC) via reduction in 
inflammation (reduced gene and protein expression of cytokines). In addition, the 
increment in circulating inflammatory cytokines levels at day 7 (IL-12, IFN-γ, and 
TNF-α) could support a role for the mixture of OA and NIC in stimulating a more rapid 
immune maturity in weaning piglets. 
Keywords: organic acids, nature-identical compounds, weaning piglet, inflammatory 
cytokines, intestinal health. 
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INTRODUCTION 
Organic acids and botanicals have long been used in pig husbandry as alternative to 
conventional antibiotic growth promoters. The efficacy of these products has been 
linked to a reduced bacterial pressure in the gut and the proposed mode of action is the 
reduction of pathogenic bacteria in the GI tract. According to the “anion model” 
proposed by Russel and Diez-Gonzalez (1998) organic acids, including those produced 
as a result of intestinal fermentation, can diffuse across the bacterial cell membrane in 
the uncharged, protonated form and dissociate inside the cell, lowering the internal pH. 
To overcome the pH reduction, several ATP-dependent systems are induced, finally 
impairing bacterial protein synthesis; furthermore, as the internal pH remains high, the 
differential pH becomes larger allowing a logarithmic intracellular accumulation of 
anions, which is believed to be the real toxicity mechanism (Russell & Diez-Gonzalez, 
1998). Botanicals and nature-identical compounds (i.e. chemically synthesized 
botanicals), instead, are proposed as membrane permeabilizers or pore-forming agents 
that would allow ion leakage and membrane potential disruption (Lambert et al., 2001; 
Nazer et al., 2005). The consistent improvement of growth performance and feed 
efficiency observed over 25 years of usage of these products in different farms with 
different genetics of animals and different sanitary pressures (Mroz, 2003; Tung & 
Pettigrew, 2006) makes unlikely that it is just a reduction of pathogenic bacteria at the 
basis of improved growth performance or feed efficiency but rather it would implicate a 
host-mediated response. 
Intestinal health is strictly connected to the barrier function and the ability to keep out 
pathogens and toxins while allowing for very efficient uptake of water and nutrients. 
The intestinal barrier is composed by a single layer of enterocytes and connecting inter-
epithelial tight junctions which are responsible of regulating the paracellular flux of 
solutes and macromolecules (Blikslager et al., 2007). When inflammation occurs, like 
at weaning, the epithelial barrier and tight junctions functionality are impaired and the 
ability of the enterocyte to absorb nutrients as well. As a result, animal growth 
performance are decreased and susceptibility to infections is increased. Therefore, 
maintaining the barrier function is a key-point in order to maintain a correct growth and 
development of the young animal. 
Aim of this study was to try to elucidate an alternative mechanism ‒ beyond the 
antibacterial effect ‒ behind organic acids and botanicals efficacy in improving growth 
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performance of pigs. We therefore assessed the impact of dietary inclusion of a 
microencapsulated mixture of sorbic, citric acid, thymol and vanillin, on measures of 
intestinal health in pigs weaned at an early age and in a relatively clean environment, in 
order to exclude a major interference of pathogenic microflora. 
 
MATERIALS AND METHODS 
Experimental Procedure 
The North Carolina State University Institutional Animal Care and Use Commitee 
approved all studies. Twenty piglets (commercial hybrids) were weaned at 18 days of 
age and placed into one of two groups (n = 10) receiving either a basal diet (control 
group) or the basal diet supplemented with a mixture of organic acids and nature 
identical compounds (OA+NIC, 5,000 mg/kg of feed, providing sorbic acid, citric acid, 
thymol and vanillin) for 2 weeks. The control diet contained 2.5% plasma protein 
(APC, Ankeny, IA), 35.5% SBM (48% CP), 58.7% corn (US #2), 1.65% dicalcium 
phosphate, 1% Limestone, and 1% corn oil, along with a vitamin and mineral premix to 
meet or exceed the nutrient requirements for this size/age of pig (NRC, 1998). No 
antibiotics were added to this diet. Individual body weights were recorded initially (d0), 
at day 7 (d7) and at day 14 (d14), and ADG was calculated. Blood samples were 
collected initially at every 7 days by venipuncture using tubes without anticoagulant, 
and sera samples were stored at ‒20°C until analysis of inflammatory cytokines. 
At the completion of the study 6 pigs per group were selected for sacrifice, sample 
collection and analysis. Sacrifice and tissue collection were spread over three days (n = 
2 piglets / group /day). Piglets were killed by penetrating captive bolt followed by 
exsanguination. Segments of jejunum and ileum were collected and immediately 
prepared for Ussing chambers analysis. Ileal mucosa scrapings were collected, snap-
frozen in liquid N2 and stored at ‒80°C until gene and protein expression analysis. 
 
Ussing Chamber Analysis 
Ussing chamber experiments were conducted according to Smith et al. (2010). 
Segments of jejunum and ileum were collected from the pig, and the mucosa was 
stripped from the seromuscular layer in oxygenated (95% O2-5% CO2) Ringer solution 
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(in mmol/l: 154 Na
+
, 6.3 K
+
, 137 Cl
‒
, 0.3 H2PO4, 1.2 Ca
2+
, 0.7 Mg
2+
, 24 HCO3
‒
; pH 
7.4). Tissues were then mounted in 1.13-cm
2
 aperture Ussing chambers and bathed on 
the serosal and mucosal sides with 10 ml of Ringer solution. The serosal bathing 
solution contained 10 mM glucose, which was osmotically balanced on the mucosal 
side with 10 mM mannitol. Bathing solutions were oxygenated (95% O2-5% CO2) and 
circulated in water-jacketed reservoirs maintained at 37°C. The spontaneous potential 
difference (PD) was measured using Ringer-agar bridges connected to calomel 
electrodes, and the PD was short-circuited through Ag-AgCl electrodes using a voltage 
clamp that corrected for fluid resistance. Tissues were maintained in the short-circuited 
state, except for short intervals to record the open-circuit PD. Trans-epithelial electrical 
resistance (TER; Ω·cm2) was calculated from the spontaneous PD and short-circuit 
current (ISC), as previously described (Argenzio & Liacos, 1990). After a 30-min 
equilibration period on Ussing chambers, TER was recorded at 15-min intervals over a 
1-h period and then averaged to derive the basal TER values for a given animal. 
Mucosal permeability was assessed measuring mucosal-to-serosal fluxes of dextran, 
according to Moeser et al. (2012). FITC-dextran 4 kDa (FD4) was added to the serosal 
bathing reservoir of Ussing chambers at a concentration of 100 mg/ml and the flux to 
the serosal compartment was measured. After a 30-min equilibration period, standards 
were taken from the serosal side of each chamber. Samples (0.5 mL) were collected 
from the serosal chambers at 30-min intervals over a 90-min period. The quantity of 
FD4 was established by measuring the fluorescence in serosal reservoir fluid samples in 
a fluorescence plate reader at 540 nm. Data are presented as the rate of FD4 flux 
(mg/cm
2
/min) over a 90-min period. 
ELISA Quantification of Inflammatory Cytokines 
Protein levels of IFN-γ, TGF-β, TNF-α, IL-6, IL-10, IL-12 were determined both in 
sera samples and in ileal samples using commercial ELISA kits specific for porcine 
cytokines (R&D Systems, Minneapolis, MN). Sera samples were prepared according to 
manufacturer’s instructions. Ileal mucosa scrapings were lysed in lysis buffer (10 mM-
Tris, 1 mM-EDTA, 0.5%-Triton X100) and homogenized using a handheld rotor-stator 
homogenizer before ELISA analysis. Analyses were performed according to 
manufacturer’s instructions. Results refer to picograms of cytokine per 100 mg of tissue 
(pg/100 mg). 
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Inflammatory Cytokines, SGLT-1 and CFTR Gene Expression Analysis 
Ileal mucosa scrapings were disrupted by grinding in liquid N2 with mortar and pestle, 
then homogenized using a handheld rotor-stator homogenizer. Total RNA was isolated 
using RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. Genomic 
DNA contamination was removed by treatment with deoxyribonuclease (Ambion 
DNA-free kit, Life Technologies, Grand Island, NY). RNA yield and quality were 
determined spectrophotometrically using A260 and A280 nm measurements. All samples 
showed A260:A280 ratio of 1.9‒2.0. A total of 1 µg of RNA was reverse transcribed with 
Superscript III (Invitrogen Life Technologies, Grand Island, NY) according to the 
manufacturer’s instructions. The resulting cDNA samples were then treated with RNase 
H (Invitrogen Life Technologies, Grand Island, NY) to ensure the removal of residual 
RNA, then cDNA was quantified with Quant-iT Oligreen ssDNA Assay (Life 
Technologies) in order to normalize the quantity of cDNA template used for 
amplification by real-time PCR. Relative quantities of the transcripts of interest were 
determined by semi-quantitative real-time PCR (My iQ Single Color Real-Time PCR 
Detection System and SybrGreen Supermix, Bio-Rad Laboratories, Hercules, CA). 
Thermocycling protocol included initial denaturation for 3 min at 95°C, then 40 cycles 
of 20 s of denaturation at 95°C followed by 20 s of annealing and extension at 60°C. 
Following amplification, all samples were subjected to a melt curve analysis to exclude 
presence of non-specific products. Gene expression was normalized using two 
housekeeping genes coding for portions of porcine ribosomal subunit 60S, such as 
ribosomal protein L35 (RPL35) and ribosomal protein L4 (RPL4). Average CT was 
determined for each gene of interest (GOI), and geometric average was calculated for 
housekeeping genes (HKs), assuming CT as number of cycles needed to reach a fixed 
arbitrary threshold. Delta CT was calculated as CT GOI−CT HKs, then a modification of 
the 2
–ΔΔC
T method was used to analyze the relative expression (fold changes), 
calculated relative to the control group (Livak & Schmittgen, 2001). 
The sequences, expected product length, accession number in the EMBL 
database/GenBank and references of porcine primers are shown in Table 1. Primer 
oligonucleotides for IL-12, tumor necrosis factor-α (TNF-α), transforming growth 
factor-β (TGF-β), sodium/glucose co-transporter 1 (SGLT-1), and cystic fibrosis 
transmembrane conductance regulator (CFTR) were designed using PrimerQuest 
software (IDT, Integrated DNA Technologies, www.idtdna.com). Primers were 
obtained from IDT, Integrated DNA Technologies (www.idtdna.com). 
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Table 1. Primers used for gene expression analysis 
Gene Primer Sequence (F and R; 5’ → 3’) Product 
lenght 
(bp) 
Product 
Tm 
(°C) 
Accession 
No. 
Reference 
IL-6 F: AGCAAGGAGGTACTGGCAGAAAACAAC 
R: GTGGTGATTCTCATCAAGCAGGTCTCC 
110 83.5 NM_2143
99.1 
Zannoni et 
al., 2011 
IL-10 F: CGGCGCTGTCATCAATTTCTG 
R: CCCCTCTCTTGGAGCTTGCTA 
89 85 NM_2140
41.1 
Duvigneau 
et al., 2005 
IL-12 F: GCCCAGGAATGTTCAAATGCCTCA 
R: AGGCAACTCTCATTCGTGGCTAGT 
199 85.5 NM_2139
93.1 
Present 
study 
TNF-α F: GCCCACGTTGTAGCCAATGTCAAA 
R: GTTGTCTTTCAGCTTCACGCCGTT 
99 87 NM_2140
22.1 
Present 
study 
TGF-β F: AGGCCGTACTGGCTCTTTACAACA 
R: TTGGTTGCCGCTTTCCACCATTAG 
134 83.5 NM_2140
15.1 
Present 
study 
IFN-γ F: GGCCATTCAAAGGAGCATGGATGT 
R: TGAGTTCACTGATGGCTTTGCGCT 
149 83.5 NM_2139
48.1 
Present 
study 
SGLT-1 F: TGCTGTTTCCAGATGATGTGGGCT 
R: TGCTGCTGCTGTTAAAGATGGACG 
198 90.5 NM_0010
12297.1 
Present 
study 
CFTR F: GAAGAACTGGATCAGGGAAGAG 
R: GAATCCCAAGACACACCATCTA 
97 84.5 NM_0011
04950.1 
Present 
study 
RPL35 F: AACCAGACCCAGAAAGAGAAC 
R: TTCCGCTGCTGCTTCTTG 
146 87.5 NM_2143
26.2 
Alexander 
et al., 2012 
RPL4 F: CAAGAGTAACTACAACCTTC 
R: GAACTCTACGATGAATCTTC 
122 84 XM_0031
21741.3 
Alexander 
et al., 2012 
F, forward primer; R, reverse primer; Tm, melting temperature; TNF-α, tumor necrosis factor-α; TGF-β, 
transforming growth factor-β; IFN-γ, interferon-γ; SGLT-1, sodium/glucose co-transporter-1; CFTR, 
cystic fibrosis transmembrane conductance regulator; RPL35, ribosomal protein L35; RPL4, ribosomal 
protein L4. 
 
Statistical Analysis 
Data were analyzed using a two-tailed Student’s t-test with the GLM procedure of SAS 
(SAS Institute Inc., release 9.2, Cary, NC). Gene expression and cytokine data were 
analyzed without covariate. Collection day was used as a covariate for the Ussing 
chamber data. Initial BW was used as a covariate for growth performance data. 
Differences were considered significant at P < 0.05, trends at 0.05 < P ≤ 0.10. 
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RESULTS 
Table 2 summarizes growth performance results. Feeding the mixture of organic acids 
and nature-identical compounds improved growth performance. Treated pigs had 
higher BW compared to controls at d14 (9.13 kg versus 8.45 kg; P < 0.05) and greater 
ADG both during the second week of the study and overall (P < 0.05). 
Table 2. Growth performance 
1
 Treatments: control = 
basal diet; OA+NIC = basal 
diet + mixture of organic 
acids and nature-identical 
compounds at 5,000 mg/kg. 
BW, body weight; ADG, 
average daily gain. 
 
 
Results from Ussing chambers analysis are reported in Fig. 1. In OA+NIC group 
intermittent short-circuit current (ISC) tended to be reduced in the ileum (P < 0.10) and 
was numerically reduced in the jejunum. In addition, dextran flux in the jejunum was 
numerically lower in treated pigs compared to controls. 
 
 
 Treatment
1
    
Item control OA+NIC  SEM P 
BW, kg      
d0 7.08 7.15  0.07 0.91 
d7 8.08 8.01  0.08 0.57 
d14 8.46 9.13  0.21 0.049 
      
ADG, g/d 
  
 
  
0 to 7d 136.77 127.40  11.72 0.59 
7 to 14d 191.63 286.87  29.57 0.049 
0 to 14d 95.89 143.60  14.78 0.049 
Fig. 1. Ussing chambers analysis of jejunum 
and ileum 
Values are least square means (n = 6) and SEM 
represented by vertical bars. 
TER = trans-epithelial electrical resistance (Ω·cm2); 
FD4 flux = mucosal-to-serosal FITC-dextran flux 
(mg/cm
2
/min); ISC = short-circuit current (µA/ cm
2
). 
Control = basal diet; OA+NIC = basal diet + mixture 
of organic acids and nature-identical compounds at 
5,000 mg/kg. 
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Figure 2 shows mRNA levels of inflammatory cytokines, SGLT-1 and CFTR in ileal 
mucosa. The group treated with OA+NIC mixture had significantly lower mRNA level 
of TGF-β and IL-12 (P = 0.04 and P = 0.003, respectively), and tended to have reduced 
mRNA level of IL-6 and IFN-γ (P < 0.10 both). SGLT-1 mRNA level was numerically 
lower in treated group compared to control, whereas CFTR gene expression was not 
affected by the treatment with OA+NIC. 
 
 
Fig. 2. Gene expression of inflammatory cytokines, SGLT-1 and CFTR in ileal mucosa 
Values are least square means and SEM (n = 6). 
Within a gene, columns with symbols are different: * = P < 0.05; ** = P < 0.01. 
A modification of the 2
–ΔΔC
T method was used to analyze the relative expression (fold changes), 
calculated relative to the control group (control), (Livak & Schmittgen, 2001). 
Control = basal diet; OA+NIC = basal diet + mixture of organic acids and nature-identical compounds at 
5,000 mg/kg. 
 
 
 
Protein levels of inflammatory cytokines in ileal mucosa are presented in Fig. 3. 
Compared to control group, OA+NIC group had numerically lower TGF-β level, 
whereas no effects were observed in IL-6, IL-10, IL-12, IFN-γ or TNF-α. 
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Fig. 3. Protein levels of inflammatory cytokines in ileal mucosa 
Values are least square means (n = 6) and SEM represented by vertical bars. 
Data refer to picograms of cytokine per 100 milligrams of tissue (pg/ 100mg) measured using ELISA 
method.  
Control = basal diet; OA+NIC = basal diet + mixture of organic acids and nature-identical compounds at 
5,000 mg/kg. 
 
 
Figure 4 shows protein levels of inflammatory cytokines in sera samples measured at 
d0, d7 and d14 of the study. At d0 no differences were observed. At d7 pigs fed with 
the mixture of organic acids and nature-identical compounds had significantly higher 
TNF-α (P < 0.01) and numerically higher IL-12, while IFN-γ tended to be higher than 
in controls (P = 0.08). At d14 IL-6 level was numerically lower in treated group 
compared to control, whereas no effects were observed on other cytokines. 
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Fig. 4. Protein levels of inflammatory cytokines in serum at d0, d7, and d14 
Values are least square means (n = 6) and SEM represented by vertical bars. 
Within a time-point (d0, d7, or d14) columns with symbols are different: * = P < 0.05; ** = P < 0.01. 
Data refer to picograms of cytokine per milliliter of serum (pg/ml) measured using ELISA method.  
Control = basal diet; OA+NIC = basal diet + mixture of organic acids and nature-identical compounds at 
5,000 mg/kg. 
 
 
DISCUSSION 
In pig feeding, the use of organic acids and botanicals has been widely accepted as tool 
to improve growth performance and control weaning-associated intestinal disorders, 
due to their acidifying and anti-microbial properties largely demonstrated and reviewed 
(Partanen & Mroz, 1999; Kroismayr et al., 2008; Suryanarayana et al., 2012). Previous 
studies from our research group showed that microencapsulation of organic acids and 
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natural identical flavors (i.e. chemically synthesized botanicals) in a lipid matrix 
allowed those compounds to be slowly released along the gut of the pig and reach the 
distal part of the intestine, where they can modulate microbial ecosystem, thus 
preventing the rapid disappearance upon exiting the stomach (Piva et al., 2007). In 
addition, when fed to weaning piglets for a 41-days post-weaning study, the 
microencapsulated mixture of organic acids and nature identical compounds improved 
growth performance as showed by higher feed intake, higher average daily gain and 
final body weight, along with better intestinal metabolism (Grilli et al., 2010). 
Our hypothesis was that, beyond the anti-microbial properties and the ability to reduce 
pathogenic bacteria in the gastro-intestinal tract, organic acids and nature-identical 
compounds may exert a direct effect on the intestinal health in weaning piglets. 
Therefore, the aim of the present study was to establish a possible mode of action of the 
mixture of organic acids and nature identical compounds on the intestinal health, by 
evaluating the effects on barrier integrity and inflammatory status in early-weaned 
piglets. 
In order to focus on the health changes induced by OA and NIC without bacterial health 
challenges, we used healthy piglets in a clean research facility, subjected to early 
weaning stress (18 days of age) to highlight the spontaneous inflammation naturally 
occurring in the intestine at weaning. In fact, in addition to the morphological and 
functional changes that impair intestinal functions, weaning is known to be associated 
with up-regulation of pro-inflammatory cytokines IL-1β, TNF-α and IL-6 (Pié et al., 
2004). Moreover, previous studies have shown that early weaning (15-18 days of age) 
resulted in consistent impairment of the development of the intestinal barrier function 
and of the mucosal immune response to pathogenic challenges with long-term 
consequences (Smith et al., 2010; McLamb et al., 2013). 
In our study, we measured the effects of the treatment with OA and NIC on the 
intestinal integrity by Ussing chamber analysis. The treatment influenced the net 
electrogenic ion transport across the intestinal epithelium in terms of intermittent short-
circuit current (ISC). Compared to control, in treated group ISC tended to be reduced in 
the jejunum and was significantly lower in the ileum. ISC is reflective of ions movement 
across the epithelium, particularly Cl
-
 and HCO3
-
 secretion, which drives fluid flux into 
the intestinal lumen, likely leading to diarrhea (McLamb et a., 2013). The reduction in 
the ISC value induced by OA and NIC particularly in the ileum (where ISC became 
negative compared to control value) may be due to a reduced secretion of Cl
-
 and 
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HCO3
-
 ions. Therefore, we analyzed the gene expression in the ileal mucosa of the 
cystic fibrosis transmembrane conductance regulator (CFTR), which is an apical anion 
channel responsible for the cAMP-dependent efflux of Cl
-
 ions into the lumen (Field, 
2003). However, CFTR mRNA level in the ileal mucosa was not different between 
control and treated animals, thus suggesting that the effect of OA and NIC on ions and 
fluids flux across the epithelium may be related not only to the trans-cellular route, but 
also to the para-cellular route. The para-cellular route involves the flux of solutes and 
compounds across the lateral inter-spaces between two adjacent cells and it is regulated 
by the tight junctions (TJ), multi-proteins complexes, that close the inter-cellular space 
and modulate para-cellular permeability (Arrieta et al., 2006). In our experiment, para-
cellular permeability was assessed by measuring the flux of dextran, an high-molecular 
weight compound that can be adsorbed only via para-cellular way. In the jejunum, the 
dextran flux was numerically lower in treated animals compared to controls. Thus, OA 
and NIC may allow tighter epithelium, reducing the leakage of ions, fluids and 
consequent risk of diarrhea. This protective action on the epithelial integrity exerted by 
OA and NIC may be explained by the effects on the inflammatory status in the ileal 
mucosa. In fact, epithelial permeability and, particularly, tight junctions status, have 
been shown to be continuously regulated by several physiological, bacterial, dietary and 
pharmacological stimuli, among which inflammatory cytokines are regarded as major 
mediators (Lallès, 2010). Especially, pro-inflammatory cytokines such as IFN-γ, TNF-
α, IL-12 and IL-1β have been demonstrated to exert a “leaky” action on the epithelium, 
inducing the opening of the tight junctions and, consequently, allowing para-cellular 
permeation to dangerous luminal compounds. The mechanisms of action involve the 
disruption of the multi-protein structure of the tight junctions. However, other 
cytokines, including IL-10 and TGF-β, have been shown to play an anti-inflammatory 
action protective of the tight junctions structure and the epithelial integrity (Al-Sadi et 
al., 2009). In our experiment, the treatment with OA and NIC modulated the 
inflammatory status in the ileal mucosa at both gene and protein expression level: 
compared to control group, mRNA levels tended to be reduced for IFN- γ and IL-6 and 
was significantly reduced for IL-12 and TGF-β; similar pattern were observed in 
protein levels. The reduction of pro-inflammatory “leaky” cytokines induced by OA 
and NIC may be supportive for a tighter and more resistant epithelium, as described 
from the Ussing chamber analysis of intestinal barrier integrity. It seems, therefore, that 
OA and NIC positively modulated the inflammatory stress in the intestinal epithelium 
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directly by reducing pro-inflammatory stimulus, rather than enhancing the anti-
inflammatory response. In this view, the reduction both in gene and protein expression 
of the anti-inflammatory cytokine TGF-β can be considered as a consequence of the 
reduced pro-inflammatory milieu in the intestinal mucosa. The immuno-modulatory 
action of the OA and NIC mixture that we observed in the present study is consistent 
with the anti-inflammatory properties ascribed to botanicals in previous works both in 
vitro and in vivo. Several plant extracts have been described to exert anti-inflammatory 
activity in cell models: carvacrol reduced the expression of pro-inflammatory cytokines 
(TNF-α, IL-1β) in porcine alveolar macrophages stimulated with LPS (Liu et al., 2012); 
thymol reduced the in vitro activation of ovine neutrophils by down-regulating the 
expression of adhesion molecules and ROS production (Farinacci et al., 2008). In 
addition, botanicals have been tested as therapeutic agents in murine models of 
inflammatory bowel disease. In rats suffering DSS-induced colitis, essential oil of 
thyme was able to reduce the inflammatory response in the colon by down-regulating 
the pro-inflammatory transcription factor NF-kB, while enhancing anti-inflammatory 
IL-10 and tight junction protein claudin-3 (Mueller et al., 2013). Moreover, vanillin is 
known to be a potent inhibitor of NF-kB and it has been tested in a murine model of 
TNBS-colitis by Wu and colleagues (2009): vanillin improved macroscopic and 
histological features of colitis by reducing NF-kB activation and the colonic expression 
of IL-1 β, TNF- α, IL-6 and IFN-γ (Wu et al., 2009). Therefore, we can hypothesize 
that, in the mixture of OA and NIC, thymol and vanillin might be responsible for the 
down-regulation of the intestinal inflammatory stress and consequent improvement of 
the barrier integrity. In addition, sorbic and citric acid, the organic acids in the mixture, 
may have improved the trophic status of the epithelium, supplying energy to intestinal 
cells. In fact, as reviewed by Suryanarayana and colleagues, organic acids act as direct 
energy source in the gut of pigs as they are intermediary products of tricarboxylic acids 
(Suryanarayana et al., 2012). Also, in-feed supplementation of sorbic acid to weaning 
piglets has been shown to improve growth performance and the proposed mechanism 
for the growth promoting effect of sorbic acid was the stimulation of the insulin-like 
growth factor (IGF) system, by increasing the hepatocyte-mediated IGF-1 gene 
expression and secretion (Luo et al., 2011). So, in our study, organic acids might have 
improved the energy status of the intestinal epithelium, while thymol and vanillin 
reducing the inflammatory stress, thus resulting in a healthier and tighter epithelium. 
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Treatment with OA and NIC also influenced the systemic immune response of the 
weaning piglets as indicated by the inflammatory cytokines levels measured in the 
serum. After the first week of treatment, the OA+NIC group had increased circulating 
levels of TNF-α and IFN-γ, as well as numerically higher IL-12, compared to control 
group. This result might appear surprising as these three cytokines are pro-
inflammatory but no adverse effects on the piglets health were observed in the present 
study, neither immuno-stimulatory responses have been ascribed to organic acids and 
botanicals in previous studies. One possible explanation may depend on the increment 
of IL-12: in fact, IL-12 is a pro-inflammatory cytokine whose expression plays a crucial 
role in coordinating innate and adaptive immune responses. Particularly, IL-12 
stimulates the production of IFN-γ by natural killer cells, T cells, macrophages and 
dendritic cells, as well as the differentiation of IFN-γ-producing T helper 1 cells, 
therefore regulating the development of the adaptive immunity (Watford et al., 2003). 
In this view, in piglets fed OA and NIC after the first week, IL-12 may have driven the 
transient over-expression of pro-inflammatory cytokines (IFN-γ and TNF-α), thus 
suggesting a more rapid development of the immune response induced by OA and NIC. 
This IL-12-mediated immuno-stimulation induced by OA and NIC was transient, as 
shown by the results at the end of the study, when no differences in the inflammatory 
cytokines levels were observed, while, conversely, IL-6 was numerically higher in 
control group compared to treated group. 
Our growth performance results showed that the supplementation with the OA and NIC 
mixture positively influenced piglets growth. Although the small number of animals 
used in the present study, the treatment with OA and NIC allowed significantly higher 
BW at the end of the study as a result of increased ADG both in the second week of 
treatment and overall in the 2-weeks experimental period. This result is consistent with 
previous findings from our research group in a large-scale feeding trial: in a 170-
weaning piglets study, feeding the same microencapsulated mixture of OA and NIC 
improved growth performance and intestinal metabolism, compared to control diet 
(Grilli et al., 2010). Despite the low number of animals, the present study confirms the 
growth promoting effect of the OA and NIC mixture and gives evidence for a possible 
mechanism of action directly on the intestinal health, beyond the well-known 
microbial-modulating action. The microencapsulation of OA and NIC in a lipid matrix 
allowed the bioactive compounds to be released in the small intestine where positively 
impacted the epithelial integrity probably by reducing the mucosal inflammatory stress.  
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Intestinal health plays a crucial role for the health of the body as the gastro-intestinal 
mucosa represents the main interface with the external environment and the microbiota 
residing along the gastro-intestinal tract. Aiming to maintain a homeostatic relationship 
between intestine and microbiota, intestinal health depends on proper barrier function, 
epithelial integrity and related mechanisms of protection (tight junctions, mucous layer, 
inflammatory and immune system). 
In pigs, weaning is associated with low growth and high incidence of intestinal 
disturbances due to several stressors that impair intestinal health. Particularly, epithelial 
barrier integrity and intestinal inflammation are essential for intestinal health and 
piglet’s health and growth. 
Therefore, the aim of the study was to evaluate the impact of different nutritional 
strategies on the intestinal health of the piglet at weaning, with special reference to the 
intestinal inflammation and the epithelial barrier integrity. In vivo studies were 
conducted to assess the potential use of zinc, tributyrin and a mixture of organic acids 
and nature-identical compounds as tools to control the inflammatory stress naturally 
occurring in the intestine of the piglet at weaning and, consequently, intestinal disorders 
and growth retard. 
Our results showed that all the dietary interventions tested were able to positively 
impact the intestinal inflammatory status and, as a consequence, improve the epithelial 
integrity by modulating tight junctions protein expression (zinc and tributyrin trials) or 
by enhancing barrier properties measured with Ussing chambers (organic acids and 
nature-identical compounds). These findings confirm the central role for intestinal 
inflammation in regulating the intestinal health not only by providing the first immune 
response against dietary or microbial challenges, but also by modulating the epithelial 
barrier structure and function. In fact, inflammatory molecules such as cytokines have 
been shown to be major mediators of the functional status of the tight junctions, 
structures that seal the inter-spaces between two epithelial cells therefore regulating the 
para-cellular permeability across the epithelium. In our trials, the dietary treatment with 
zinc, tributyrin and organic acids and nature-identical compounds showed effectiveness 
in reducing the intestinal inflammatory stress, as suggested by reduced expression of 
inflammatory cytokines. This reduction of inflammatory stress attenuated the risk of 
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cytokine-mediated epithelial disruption and intestinal damage. Tighter epithelium may, 
therefore, provide more adequate barrier function and help to maintain intestinal health. 
Compared to studies in literature about the dietary supplementation of weaning diets 
with zinc oxide or organic acids and nature-identical compounds, our work gives 
evidence that microencapsulation allowed to deliver those bio-active compounds 
precisely to the small intestine of the piglet as critical target-site for the control of 
weaning-associated disorders. Consistently with previous results from or research 
group, microencapsulation of compounds in a lipid matrix provided gastro-protection 
and targeted release of them in the small intestine where they could modulate 
inflammatory stress and epithelial integrity. Similarly, concerning tributyrin trial, 
microencapsulation of tributyrin appeared a valid tool to increase the amount of butyric 
acid reaching the colonic epithelium, as major site for exerting its beneficial actions. 
With reference to the zinc trials, in addition to the above-described advantages, 
microencapsulation of zinc oxide resulted a valid approach to reduce the usual high 
dosage of zinc oxide. In fact, zinc oxide is widely used at high – pharmacological –
dosage (2000‒3000 mg/kg) in weaning diets to control diarrhea and improve growth, 
but increasing concerns on heavy metals excretion in manure in Europe had imposed 
caution to its use. In our experiments, low doses of microencapsulated zinc oxide were 
able to positively impact ileal architecture, inflammatory status and epithelial integrity, 
therefore microencapsulated zinc oxide has been proposed as an effective and 
environmentally safe alternative to pharmacological zinc oxide. 
Along to the improved intestinal inflammatory status and epithelial integrity, zinc trial 
and organic acid and nature-identical compounds trial showed better intestinal health 
induced by supplements successfully resulted in improved growth performance. This 
result fulfills the main goal of pig production as weaning-associated growth failure is 
one of the most important problems for pig productivity. 
To conclude, this work shows that dietary supplementation with bio-active substances 
such as zinc, tributyrin and organic acids and nature-identical compounds may improve 
intestinal health of weaning piglets by modulating intestinal inflammatory stress and 
barrier integrity and allowing better piglet’s health, growth and productivity. 
 
REFERENCES 
CHAPTER 8 
 
95 
 
 
 
 
CHAPTER 8 
REFERENCES 
  
REFERENCES 
CHAPTER 8 
 
96 
  
REFERENCES 
CHAPTER 8 
 
97 
Alexander, L. S., B. S. Seabolt, R. P. Rhoads, and C. H. Stahl. 2012. Neonatal 
phosphate nutrition alters in vivo and in vitro satellite cell activity in pigs. Nutrients 
4:436–448. 
Al-Sadi R. M., and T. Y. Ma. 2007. IL-1beta causes an increase in intestinal epithelial 
tight junction permeability. J. Immunol.178(7):4641–4649. 
Al-Sadi, R., M. Boivin, and T. Ma. 2009. Mechanism of cytokine modulation of 
epithelial tight junction barrier. Front Biosci (Landmark Ed) 14:2765–2778. 
Anderson, J. M. 2001. Molecular structure of tight junctions and their role in epithelial 
transport. Physiology 16:126–130. 
AOAC. 2000. Official Methods of Analysis. 17th ed. Assoc. Off. Anal. Chem., 
Gaithersburg, MD. 
Argenzio, R. A., and J. A. Liacos. 1990. Endogenous prostanoids control ion transport 
across neonatal porcine ileum in vitro. Am. J. Vet. Res. 51:747–751. 
Arrieta, M. C., L. Bistritz, and J. B. Meddings. 2006. Alterations in intestinal 
permeability. Gut 55:1512–1520. 
Barreau, F., and J. Hugot. 2014. Intestinal barrier dysfunction triggered by invasive 
bacteria. Curr. Opin. Microbiol. 17C:91–98. 
Biagi, G., A. Piva, M. Moschini, E. Vezzali, and F. X. Roth. 2006. Effect of gluconic 
acid on piglet growth performance, intestinal microflora, and intestinal wall 
morphology. J. Anim. Sci. 84:370–378. 
Blikslager, A. T., A. J. Moeser, J. L. Gookin, S. L. Jones, and J. Odle. 2007. 
Restoration of barrier function in injured intestinal mucosa. Physiol. Rev. 87(2):545‒
564. 
Boudry, G., V. Péron, I. Le Huërou-Luron, J. P. Lallès, and B. Sève. 2004. Weaning 
induces both transient and long-lasting modifications of absorptive, secretory, and 
barrier properties of piglet intestine. J. Nutr. 134:2256–2262. 
Brown, D. C., C. V. Maxwell, G. F. Erf, M. E. Davis, S. Singh, and Z. B. Johnson. 
2006. The influence of different management systems and age on intestinal 
REFERENCES 
CHAPTER 8 
 
98 
morphology, immune cell numbers and mucin production from goblet cells in post-
weaning pigs. Vet. Immunol. Immunopathol. 111(3–4):187–198. 
Bruewer, M., M. Utech, A. I. Ivanov, A. M. Hopkins, C. A. Parkos, and A. Nusrat. 
2005. Interferon-gamma induces internalization of epithelial tight junction proteins via 
a macropinocytosis-like process. FASEB J. 19:923–933. 
Campbell, J. M., J. D. Crenshaw, and J. Polo. 2013. The biological stress of early 
weaned piglets. J Anim Sci Biotechnol 4(1):19–22. 
Carlson, D., J. Sehested, and H. D. Poulsen. 2006. Zinc reduces the 
electrophysiological responses in vitro to basolateral receptor mediated secretagogues 
in piglet small intestinal epithelium. Comp. Biochem. Physiol., Part A Mol. Integr. 
Physiol. 144:514–519. 
Carlson, M. S., G. M. Hill, and J. E. Link. 1999. Early- and traditionally weaned 
nursery pigs benefit from phase-feeding pharmacological concentrations of zinc oxide: 
effect on metallothionein and mineral concentrations. J. Anim. Sci. 77:1199–1207. 
Case, C. L., and M. S. Carlson. 2002. Effect of feeding organic and inorganic sources 
of additional zinc on growth performance and zinc balance in nursery pigs. J. Anim. 
Sci. 80:1917–1924. 
Chapman, M. A., M. F. Grahn, M. Hutton, and N. S. Williams. 1995. Butyrate 
metabolism in the terminal ileal mucosa of patients with ulcerative colitis. Br. J. Surg. 
82:36–38. 
Deli, M. 2009. Potential use of tight junction modulators to reversibly open 
membranous barriers and improve drug delivery. Biochim. Biophys. Acta 1788(4):892–
910. 
Di Giancamillo, A., F. Vitari, G. Savoini, V. Bontempo, C. Bersani, V. Dell'Orto, and 
C. Domeneghini. 2008. Effects of orally administered probiotic Pediococcus 
acidilactici on the small and large intestine of weaning piglets. A qualitative and 
quantitative micro-anatomical study. Histol. Histopathol. 23:651–664. 
REFERENCES 
CHAPTER 8 
 
99 
Duvigneau, J. C., R. T. Hartl, S. Groiss, and M. Gemeiner. 2005. Quantitative 
simultaneous multiplex real-time PCR for the detection of porcine cytokines. J. 
Immunol. Methods 306:16–27. 
Dyer, J., K. B. Hosie, and S. P. Shirazi-Beechey. 1997. Nutrient regulation of human 
intestinal sugar transporter (SGLT1) expression. Gut 41:56–59. 
EU. 2003. Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the 
conditions for authorisation of a number of additives in feedingstuffs belonging to the 
group of trace elements. Official Journal of the European Union L187:11–15. 
Faa, G., V. M. Nurchi, A. Ravarino, D. Fanni, S. Nemolato, C. Gerosa, P. Van Eyken, 
and K. Geboes A. 2008. Zinc in gastrointestinal and liver disease. Coord Chem Rev 
252:1257–1269. 
Fanning, A. S., B. J. Jameson, L. A. Jesaitis, and J. M. Anderson. 1998. The tight 
junction protein ZO-1 establishes a link between the transmembrane protein occludin 
and the actin cytoskeleton. J. Biol. Chem. 273:29745–29753. 
Farinacci, M., M. Colitti, S. Sgorlon, and B. Stefanon. 2008. Immunomodulatory 
activity of plant residues on ovine neutrophils. Vet. Immunol. Immunopathol. 126(1-
2):54‒63. 
Field, M. 2003. Intestinal ion transport and the pathophysiology of diarrhea. J. Clin. 
Invest. 111:931–943. 
Gálfi, P., and J. Bokori. 1990. Feeding trial in pigs with a diet containing sodium n-
butyrate. Acta Vet. Hung. 38(1–2):3–17. 
Garrett, W. S., J. I. Gordon, and L. H. Glimcher. 2010. Homeostasis and inflammation 
in the intestine. Cell 140(6):859–870. 
Gaschott, T., D. Steinhilber, V. Milovic, and J. Stein. 2001. Tributyrin, a stable and 
rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of 
dihydroxycholecalciferol in human colon cancer cells. J. Nutr. 131:1839–1843. 
Gitter, A., K. Bendfeldt, J. D. Schulzke, and M. Fromm. 2000. Leaks in the epithelial 
barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 
14:1749–1753. 
REFERENCES 
CHAPTER 8 
 
100 
Grilli, E., A. Gallo, M. Fustini, P. Fantinati, and A. Piva. 2013. Microencapsulated 
sodium selenite supplementation in dairy cows: effects on selenium status. Animal 
7:1944–1949. 
Grilli, E., M. R. Messina, M. Tedeschi, and A. Piva. 2010. Feeding a 
microencapsulated blend of organic acids and nature identical compounds to weaning 
pigs improved growth performance and intestinal metabolism. Livest Sci 133:173–175. 
Guttman, J. A., and B. B. Finlay. 2009. Manipulation of host-cell pathways by bacterial 
pathogens. Nature 449(7164):827–834. 
Guzman, J. R., V. S. Conlin, and C. Jobin. 2013. Diet, microbiome, and the intestinal 
epithelium: an essential triumvirate? Biomed Res Int 2013:425146–425158. 
Hahn, J. D. and D. H. Baker. 1993. Growth and plasma zinc responses of young pigs 
fed pharmacologic levels of zinc. J Anim. Sci. 71:3020–3024. 
Heo, J. M., F. O. Opapeju, J. R. Pluske, J. C. Kim, D. J. Hampson, and C. M. Nyachoti. 
2013. Gastrointestinal health and function in weaned pigs: a review of feeding 
strategies to control post-weaning diarrhoea without using in-feed antimicrobial 
compounds. J Anim Physiol Anim Nutr (Berl) 97(2):207–237. 
Hooper, L. V., and A. J. MacPherson. 2010. Immune adaptations that maintain 
homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10:159–169. 
Hou, Y. Q., Y. L. Liu, J. Hu and W. H. Shen. 2006. Effects of lactitol and tributyrin on 
growth performance, small intestinal morphology and enzyme activity in weaned pigs. 
Asian-Aust. J. Anim. Sci. 19(10):1470‒1477. 
Hou, Y., L. Wang, D. Yi, B. Ding, X. Chen, Q. Wang, H. Zhu, Y. Liu, Y. Yin, J. Gong, 
and G. Wu. 2014. Dietary supplementation with tributyrin alleviates intestinal injury in 
piglets challenged with intrarectal administration of acetic acid. Br. J. Nutr. 1‒11. 
[Epub ahead of print] 
Hu, C., J. Song, Y. Li, Z. Luan, and K. Zhu. 2013. Diosmectite-zinc oxide composite 
improves intestinal barrier function, modulates expression of pro-inflammatory 
cytokines and tight junction protein in early weaned pigs. Br. J. Nutr. 110:681–688. 
REFERENCES 
CHAPTER 8 
 
101 
Jensen-Waern, M., L. Melin, R. Lindberg, A. Johannisson, L. Petersson, and P. 
Wallgren. 1998. Dietary zinc oxide in weaned pigs--effects on performance, tissue 
concentrations, morphology, neutrophil functions and faecal microflora. Res. Vet. Sci. 
64:225–231. 
Katouli, M., L. Melin, M. Jensen-Waern, P. Wallgren, and R. Möllby. 1999. The effect 
of zinc oxide supplementation on the stability of the intestinal flora with special 
reference to composition of coliforms in weaned pigs. J. Appl. Microbiol. 87:564–573. 
Kim, J. C., C. F. Hansen, B. P. Mullan, and J. R. Pluske. 2012. Nutrition and pathology 
of weaner pigs: Nutritional strategies to support barrier function in the gastrointestinal 
tract. Anim. Feed Sci. Technol. 173(1–2):3–16. 
Kim, J. J., and W. I. Khan. 2013. Goblet cells and mucins: role in innate defense in 
enteric infections. Pathogens 2:55‒70. 
Kim, Y. S., and S. B. Ho. 2010. Intestinal goblet cells and mucins in health and disease: 
recent insights and progress. Curr Gastroenterol Rep 12(5):319–330. 
King, M. R., P. C. H. Morel, J. R. Pluske, and W. H. Hendriks. 2008. A comparison of 
the effects of dietary spray-dried bovine colostrum and animal plasma on growth and 
intestinal histology in weaner pigs. Livest Sci 119(1–3):167–173. 
Kotler, B. M., J. E. Kerstetter, and K. L. Insogna. 2013. Claudins, dietary milk proteins, 
and intestinal barrier regulation. Nutr. Rev. 71:60–65. 
Kroismayr, A., K. Schedle, J. Sehm, M. Pfaffl, C. Plitzner, H. Foissy, T. Ettle, H. 
Mayer, M. Schreiner, and W. Windisch. 2008. Effects of antimicrobial feed additives 
on gut microbiology and blood parameters of weaned piglets. Die Bodenkultur 59(1–
4):111–120. 
Lallès, J. P. 2010. Basis and regulation of gut barrier function and epithelial cell 
protection: application to the weaned pig. In: J Doppenberg and P van der Aar, editors, 
Dynamics in animal nutrition. 1st ed. Wageningen Academic Pub, Wageningen. p. 31–
51. 
REFERENCES 
CHAPTER 8 
 
102 
Lallès, J. P., P. Bosi, P. Janczyk, S. J. Koopmans, and D. Torrallardona. 2009. Impact 
of bioactive substances on the gastrointestinal tract and performance of weaned piglets: 
a review. Animal 3:1625‒1643. 
Lambert, R. J., P. N. Skandamis, P. J. Coote, and G. J. Nychas. 2001. A study of the 
minimum inhibitory concentration and mode of action of oregano essential oil, thymol 
and carvacrol. J. Appl. Microbiol. 91(3):453‒462. 
Lawlor, P. G., P. B. Lynch, P. J. Caffrey, J. J. O'Reilly, and M. K. O'Connell. 2005. 
Measurements of the acid-binding capacity of ingredients used in pig diets. Ir Vet J 
58:447–452. 
Le Dividich, I., and P. Herpin. 1994. Effects of climatic conditions on the performance, 
metabolism and health status of weaned piglets: a review. Livest. Prod. Sci. 38:79–90. 
Le Gall, M., M. Gallois, B. Sève, I. Louveau, J. J. Holst, I. P. Oswald, J. P. Lallès, and 
P. Guilloteau. 2009. Comparative effect of orally administered sodium butyrate before 
or after weaning on growth and several indices of gastrointestinal biology of piglets. Br. 
J. Nutr. 102:1285‒1296. 
Leonel, A. J., and J. I. Alvarez-Leite. 2012. Butyrate: implications for intestinal 
function. Curr Opin Clin Nutr Metab Care 15:474‒479. 
Leonel, A. J., L. G. Teixeira, R. P. Oliveira, A. F. Santiago, N. V. Batista, T. R. 
Ferreira, R. C. Santos, V. N. Cardoso, D. C. Cara, A. M. Faria, and J. Alvarez-Leite. 
2013. Antioxidative and immunomodulatory effects of tributyrin supplementation on 
experimental colitis. Br. J. Nutr. 109(8):1396–1407. 
Li, X., J. Yin, D. Li, X. Chen, J. Zang, and X. Zhou. 2006. Dietary supplementation 
with zinc oxide increases IGF-I and IGF-I receptor gene expression in the small 
intestine of weanling piglets. J. Nutr. 136:1786–1791. 
Linden, D. R., J. X. Chen, M. D. Gershon, K. A. Sharkey, and G. M. Mawe. 2003. 
Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. 
Am. J. Physiol. Gastrointest. Liver Physiol. 285:G207–216.  
REFERENCES 
CHAPTER 8 
 
103 
Liu, Y., M. Song, T. M. Che, D. Bravo and J. E. Pettigrew. 2012. Anti-inflammatory 
effects of several plant extracts on porcine alveolar macrophages in vitro. J. Anim. Sci. 
90:2774‒2783. 
Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 
25:402–408. 
Luo, Z. F., X. L. Fang, G. Shu, S. B. Wang, X. T. Zhu, P. Gao, L. L. Chen, C. Y. Chen, 
Q. Y. Xi, Y. L. Zhang, and Q. Y. Jiang. 2011. Sorbic acid improves growth 
performance and regulates insulin-like growth factor system gene expression in swine. 
J. Anim. Sci. 89:2356‒2364. 
Ma, X., P. X. Fan, L. S. Li, S. Y. Qiao, G. L. Zhang, and D. F. Li. 2012. Butyrate 
promotes the recovering of intestinal wound healing through its positive effect on the 
tight junctions. J. Anim. Sci. 90(Suppl 4):266–268. 
Madara, J. L., and J. Stafford. 1989. Interferon-gamma directly affects barrier function 
of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:724–727. 
Manzanilla, E. G., M. Nofrarías, M. Anguita, M. Castillo, J. F. Perez, S. M. Martín-
Orúe, C. Kamel, and J. Gasa. 2006. Effects of butyrate, avilamycin, and a plant extract 
combination on the intestinal equilibrium of early-weaned pigs. J. Anim. Sci. 84:2743–
2751. 
Matter, K., and M. S. Balda. 2003. Signalling to and from tight junctions. Nat. Rev. 
Mol. Cell Biol. 4:225–236. 
Mavromichalis, I., C. M. Peter, T. M. Parr, D. Ganessunker, and D. H. Baker. 2000. 
Growth-promoting efficacy in young pigs of two sources of zinc oxide having either a 
high or a low bioavailability of zinc. J. Anim. Sci. 78:2896–2902. 
McCracken, B. A., M. E. Spurlock, M. A. Roos, F. A. Zuckermann, and H. R. Gaskins. 
1999. Weaning anorexia may contribute to local inflammation in the piglet small 
intestine. J. Nutr. 129(3):613–619. 
McLamb, B. L., A. J. Gibson, E. L. Overman, C. Stahl, and A. J. Moeser. 2013. Early 
weaning stress in pigs impairs innate mucosal immune responses to enterotoxigenic E. 
REFERENCES 
CHAPTER 8 
 
104 
coli challenge and exacerbates intestinal injury and clinical disease. PLoS ONE 
8(4):e59838. 
Mentschel, J., and R. Claus. 2003. Increased butyrate formation in the pig colon by 
feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the 
stem cell compartment. Metab. Clin. Exp. 52:1400‒1405. 
Moeser, A. J., L. B. Borst, B. L. Overman, and J. S. Pittman. 2012. Defects in small 
intestinal epithelial barrier function and morphology associated with peri-weaning 
failure to thrive syndrome (PFTS) in swine. Res. Vet. Sci. 93(2):975–982. 
Moran, G. W., C. O'Neill, and J. T. McLaughlin. 2012. GLP-2 enhances barrier 
formation and attenuates TNFα-induced changes in a Caco-2 cell model of the 
intestinal barrier. Regul. Pept. 178(1–3):95–101. 
Mroz, Z. 2003. Organic acids of various origin and physico-chemical forms as potential 
alternatives to antibiotic growth promoters for pigs. Pages 267–293 in Proc. of 9th Int. 
Symp. Dig. Physiol. In Pigs, Banff, AB, Canada. 
Mueller, K., N. M. Blum, and A. S. Mueller. 2013. Examination of the Anti-
Inflammatory, Antioxidant, and Xenobiotic-Inducing Potential of Broccoli Extract and 
Various Essential Oils during a Mild DSS-Induced Colitis in Rats. ISRN Gastroenterol. 
2013:710856‒710870. 
National Research Council. 1998. Nutrient Requirements of Swine. 10th ed. National 
Academy Press, Washington, DC. 
National Research Council. 2012. Nutrient Requirements of Swine. 11th ed. National 
Academy Press, Washington, DC. 
Nazer, A. I., A. Kobilinsky, J. L. Tholozan, and F. Dubois-Brissonnet. 2005. 
Combinations of food antimicrobials at low levels to inhibit the growth of Salmonella 
sv. Typhimurium: a synergistic effect? Food Microbiol. 22:391‒398. 
Noblet, J., H. Fortune, X. S. Shi, and S. Dubois. 1994. Prediction of net energy value of 
feeds for growing pigs. J. Anim. Sci. 72:344‒354. 
REFERENCES 
CHAPTER 8 
 
105 
Ohata, A., M. Usami, and M. Miyoshi. 2005. Short-chain fatty acids alter tight junction 
permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition 
21:838‒847. 
Ou, D., D. Li, Y. Cao, X. Li, J. Yin, S. Qiao, and G. Wu. 2007. Dietary 
supplementation with zinc oxide decreases expression of the stem cell factor in the 
small intestine of weanling pigs. J. Nutr. Biochem. 18:820–826. 
Partanen, K. H., and Z. Mroz. 1999. Organic acids for performance enhancement in pig 
diets. Nutr Res Rev 12(1):117‒145. 
Patel, A., M. Mamtani, M. J. Dibley, N. Badhoniya, and H. Kulkarni. 2010. 
Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic 
review. PLoS One 5:e10386 
Peng, L., Z. R. Li, R. S. Green, I. R. Holzman, and J. Lin. 2009. Butyrate enhances the 
intestinal barrier by facilitating tight junction assembly via activation of AMP-activated 
protein kinase in Caco-2 cell monolayers. J. Nutr. 139:1619‒1625. 
Perry, D. K., M. J. Smyth, H. R. Stennicke, G. S. Salvesen, P. Duriez, G. G. Poirier, 
and Y. A. Hannun. 1997. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. 
A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272:18530–18533. 
Pié, S., J. P. Lallès, F. Blazy, J. Laffitte, B. Sève, and I. P. Oswald. 2004. Weaning is 
associated with an upregulation of expression of inflammatory cytokines in the intestine 
of piglets. J. Nutr. 134(3):641–647. 
Piva, A., A. Panciroli, E. Meola, and A. Formigoni. 1996. Lactitol enhances short-chain 
fatty acid and gas production by swine cecal microflora to a greater extent when 
fermenting low rather than high fiber diets. J. Nutr. 126(1):280–289. 
Piva, A., M. Morlacchini, G. Casadei, P. P. Gatta, G. Biagi, and A. Prandini. 2002a. 
Sodium butyrate improves growth performance of weaned piglets during the first 
period after weaning. Ital. J. Anim. Sci. 1:35–41. 
Piva, A., A. Prandini, L. Fiorentini, M. Morlacchini, F. Galvano, and J. B. Luchansky. 
2002b. Tributyrin and lactitol synergistically enhanced the trophic status of the 
REFERENCES 
CHAPTER 8 
 
106 
intestinal mucosa and reduced histamine levels in the gut of nursery pigs. J. Anim. Sci. 
80:670–680. 
Piva, A., V. Pizzamiglio, M. Morlacchini, M. Tedeschi, and G. Piva. 2007. Lipid 
microencapsulation allows slow release of organic acids and natural identical flavors 
along the swine intestine. J. Anim. Sci. 85:486–493. 
Pluske, J. R. 2013. Feed- and feed additives-related aspects of gut health and 
development in weanling pigs. J Anim Sci Biotechnol 4(1):1. 
Pluske, J. R., D. J. Hampson, and I. H. Williams. 1997. Factors influencing the 
structure and function of the small intestine in the weaned pig: a review. Livest. Prod. 
Sci. 51:215–236. 
Poulsen, H. D. 1989. Zinc oxide for pigs during the weaning period. Publication no. 
746. Danish Institute of Animal Science, Tjele, Denmark. 
Prasad, A. S. 2008. Zinc in human health: effect of zinc on immune cells. Mol. Med. 
14:353–357. 
Roediger, W. E. 1980. Role of anaerobic bacteria in the metabolic welfare of the 
colonic mucosa in man. Gut 21:793–798. 
Roselli, M., A. Finamore, I. Garaguso, M. S. Britti, and E. Mengheri. 2003. Zinc oxide 
protects cultured enterocytes from the damage induced by Escherichia coli. J. Nutr. 
133:4077–4082. 
Russell, J. B., and F. Diez-Gonzalez. 1998. The effects of fermentation acids on 
bacterial growth. Adv. Microb. Physiol. 39:205‒234. 
Sargeant, H. R., K. J. McDowall, H. M. Miller, and M. A. Shaw. 2010. Dietary zinc 
oxide affects the expression of genes associated with inflammation: transcriptome 
analysis in piglets challenged with ETEC K88. Vet. Immunol. Immunopathol. 
137:120–129. 
Sargeant, H. R., H. M. Miller, and M.A. Shaw. 2011. Inflammatory response of porcine 
epithelial IPEC J2 cells to enterotoxigenic E. coli infection is modulated by zinc 
supplementation. Mol. Immunol. 48:2113–2121. 
REFERENCES 
CHAPTER 8 
 
107 
Schell, T. C. and E. T. Kornegay. 1996. Zinc concentration in tissues and performance 
of weanling pigs fed pharmacological levels of zinc from ZnO, Zn-methionine, Zn-
lysine, or ZnSO4. J. Anim. Sci. 74:1584‒1593. 
Sekirov, I., S. L. Russell, L. C. M. Antunes, and B. Finlay. 2010. Gut microbiota in 
health and disease. Physiol. Rev. 90:859–904. 
Smith, F., J. E. Clark, B. L. Overman, C. C. Tozel, J. H. Huang, J. E. Rivier, A. T. 
Blikslager, and A. J. Moeser. 2010. Early weaning stress impairs development of 
mucosal barrier function in the porcine intestine. Am. J. Physiol. Gastrointest. Liver 
Physiol. 298:G352–G363. 
Suryanarayana, M. V. A. N., J. Suresh, and M. V. Rajasekhar. 2012. Organic acids in 
swine feeding - A Review. Agricultural Science Research Journals 2:523‒533. 
Tung, C. M., and J. E. Pettigrew. 2006. Critical review of acidifiers. Department of 
Animal Sciences, University of Illinois. 
http://www.pork.org/FileLibrary/ResearchDocuments/05-169-PETTIGREW-
UofILL.pdf. Accessed 12 March, 2014. 
Turner, R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. 
Immunol. 9:799–809. 
Van Itallie, C. M., and J. M. Anderson. 2004. The molecular physiology of tight 
junction pores. Physiology (Bethesda) 19:331–338. 
Wang, Y. Z., Z. R. Xu, W. X. Lin, H. Q. Huang and Z. Q. Wang. 2004. Developmental 
gene expression of antimicrobial peptide PR-39 and effect of zinc oxide on gene 
regulation of PR-39 in piglets. Asian-australas. J. Anim. Sci. 17:1635–1640. 
Watford, W. T., M. Moriguchi, A. Morinobu, and J. J. O'Shea. 2003. The biology of 
IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor 
Rev. 14(5):361‒368. 
Wedekind, K. J., A. J. Lewis, M. A. Giesemann and P. S. Miller. 1994. Bioavailability 
of zinc from inorganic and organic sources for pigs fed corn-soybean meal diets. J. 
Anim. Sci. 72:2681‒2689. 
REFERENCES 
CHAPTER 8 
 
108 
Whittemore, C. T. 1987. Elements of Pig Science. Longman handbooks in agriculture, 
Harlow, UK. 
Woodward, A. D., P. R. Regmi, M. G. Gänzle, T. A. van Kempen, and R. T. Zijlstra. 
2012. Slowly digestible starch influences mRNA abundance of glucose and short-chain 
fatty acid transporters in the porcine distal intestinal tract. J. Anim. Sci. 90(Suppl. 
4):80–82. 
Woyengo, T. A., J. C. Rodriguez-Lecompte, O. Adeola, and C. M. Nyachoti. 2011. 
Histomorphology and small intestinal sodium-dependent glucose transporter 1 gene 
expression in piglets fed phytic acid and phytase-supplemented diets. J. Anim. Sci. 
89:2485–2490. 
Wu, S. L., J. C. Chen, C. C. Li, H. Y. Lo, T. Y. Ho, and C. Y. Hsiang. 2009. Vanillin 
improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice. J. 
Pharmacol. Exp. Ther. 330(2):370‒376. 
Yin, J., X. Li, D. Li, T. Yue, Q. Fang, J. Ni, X. Zhou, and G. Wu. 2009. Dietary 
supplementation with zinc oxide stimulates ghrelin secretion from the stomach of 
young pigs. J. Nutr. Biochem. 20:783–790. 
Zannoni, A., M. Giunti, C. Bernardini, F. Gentilini, A. Zaniboni, M. L. Bacci, and M. 
Forni. 2012. Procalcitonin gene expression after LPS stimulation in the porcine animal 
model. Res. Vet. Sci. 93:921–927. 
Zhang, B., and Y. Guo. 2009. Supplemental zinc reduced intestinal permeability by 
enhancing occludin and zonula occludens protein-1 (ZO-1) expression in weaning 
piglets. Br. J. Nutr. 102:687–693. 
 
